DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparation and uses

ABSTRACT

A DNA encoding an enzyme, which forms non-reducing saccharides having trehalose structure as an end unit from amylaceous saccharides having a degree of glucose polymerization of 3 or higher, enables an industrial-scale production of a recombinant enzyme with such enzyme activity. Non-reducing saccharides obtainable by the recombinant enzyme can be used in a variety of food products, cosmetics, pharmaceuticals and feeds because of their substantial non-reducibility, mild and high-quality sweetness, adequate viscosity, and moisture-retaining ability.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a division of copending parent application Ser. No. 08/393,540, filed Feb. 23, 1995.

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates to a novel DNA encoding an enzyme which forms non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher, and a recombinant DNA and enzyme containing the DNA as well as to a transformant. The present invention further relates to preparations and uses thereof.

2. Description of the Prior Art

Trehalose is a disaccharide which consists of 2 glucose molecules that are linked together with their reducing groups, and, naturally, it is present in fungi, algae, insects, etc., in an extremely small quantity. Having no reducing residue within the molecule, trehalose does not cause an unsatisfactory browning reaction even when heated in the presence of amino acids or the like, and because of this it can sweeten food products without fear of causing unsatisfiable coloration and deterioration. Trehalose, however, is far from being readily prepared in a desired amount by conventional production methods, and, actually, it has rarely been used for sweetening food products.

Conventional production methods are roughly classified into 2 groups, i.e. the one using cells of microorganisms and the other employing a multi-enzymatic system wherein enzymes are allowed to act on saccharides. The former, as disclosed in Japanese Patent Laid-Open No. 154,485/75, is a method comprising growing microorganisms such as bacteria and yeasts in nutrient culture media, and collecting trehalose from the proliferated cells in the resultant cultures. The latter, as disclosed in Japanese Patent Laid-Open No. 216,695/83, is a method comprising providing maltose as a substrate, allowing a multi-enzymatic system using maltose- and trehalose-phosphorylases to act on maltose, and recovering the formed trehalose from the reaction system. Although the former facilitates growth of microorganisms with relative ease, it requires complex sequential complicated steps for collecting trehalose from the microorganisms containing only 15 w/w % trehalose, on a dry solid basis (d.s.b.). While the latter enables separating of trehalose with relative ease, but it is theoretically difficult to increase the trehalose yield by allowing enzymes to act on substrates at a considerably-high concentration because the enzymatic reaction in itself is an equilibrium reaction of 2 different types of enzymes and the equilibrium point constantly inclines to the side of forming glucose phosphate.

In view of the foregoing, the present inventors energetically screened enzymes which form saccharides having trehalose structure from amylaceous saccharides, and found that microorganisms such as those of the species Rhizobium sp. M-11 and Arthrobacter sp. Q36 produce a novel enzyme which forms non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher. Before or after this finding, it was revealed that such a non-reducing saccharide is almost quantitatively hydrolyzed into trehalose and glucose and/or maltooligosaccharides by another enzyme produced by the same microorganisms as mentioned above. Since using a combination use of these enzymes enables the formation of a desired amount of trehalose with relative ease, the aforementioned objects relating to trehalose would be completely overcome. The low level production of the novel enzyme by such a microorganism, i.e. in a relatively-large scale culture present a drawback in industrially producing trehalose and/or non-reducing saccharides having trehalose structure as an end unit.

Recombinant DNA technology has made a remarkable progress in recent years. At present, even an enzyme whose total amino acid sequence has not been revealed can be readily prepared in a desired amount, if a gene encoding the enzyme was once isolated and the base sequence was decoded, by preparing a recombinant DNA which contains a DNA encoding the enzyme, introducing the recombinant DNA into microorganisms or cells of plants and animals, and culturing the resultant transformants. With this background, a gene encoding the enzyme and its base sequence we urgently sought.

SUMMARY OF THE INVENTION

It is an object of the present invention to provide a DNA encoding an enzyme which forms non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher.

It is a further object of the present invention to provide a recombinant DNA which contains the DNA and a self-replicable vector.

It is yet another object of the present invention to provide a recombinant enzyme, which forms non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher, by means of recombinant DNA technology.

It is another object of the present invention to provide a transformant obtainable by introducing the recombinant DNA into a suitable host.

It is a further object of the present invention to provide a preparation of the recombinant enzyme.

It is yet another object of the present invention to provide a method to convert reducing amylaceous saccharides by using the recombinant enzyme.

The first object of the present invention is attained by a DNA encoding an enzyme which forms non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher.

The second object of the present invention is attained by a replicable recombinant DNA which contains a self-replicable vector and a DNA which encodes a non-reducing saccharide-forming enzyme.

The third object of the present invention is attained by a recombinant enzyme which forms non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher.

The fourth object of the present invention is attained by a transformant into which a replicable recombinant DNA containing a self-replicable vector and a DNA encoding an enzyme which forms non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher.

The fifth object of the present invention is attained by a process for producing a recombinant enzyme, which contains a step of culturing a transformant capable of forming the recombinant enzyme, and collecting the enzyme from the resultant culture.

The sixth object of the present invention is attained by a method for converting reducing amylaceous saccharides, which contains a step of allowing the recombinant enzyme to act on reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher to form from them non-reducing saccharides having trehalose structure as an end unit.

BRIEF DESCRIPTION OF THE ACCOMPANYING DRAWINGS

FIG. 1 shows the optimum temperature of enzyme M-11.

FIG. 2 shows the optimum temperature of enzyme Q36.

FIG. 3 shows the optimum pH of enzyme M-11.

FIG. 4 shows the optimum pH of enzyme Q36.

FIG. 5 shows the thermal stability of enzyme M-11.

FIG. 6 shows the thermal stability of enzyme Q36.

FIG. 7 shows the pH stability of enzyme M-11.

FIG. 8 shows the pH stability of enzyme Q36.

FIG. 9 is a restriction map of the recombinant DNA pBMT7 according to the present invention. In the figure, a bold lined represents a DNA encoding enzyme M-11.

FIG. 10 is a restriction map of the recombinant DNA pBQT13 according to the present invention. In the figure, a bold lined represents a DNA encoding enzyme Q36.

DETAILED DESCRIPTION OF THE INVENTION

The DNA according to the present invention exerts the production of the non-reducing saccharide-forming enzyme encoded by the DNA in a manner that the DNA is inserted into an appropriate self-replicable vector to form a replicable recombinant DNA, followed by introducing the recombinant DNA into a host, which is incapable of producing the enzyme but readily replicable, to form a transformant.

Although the recombinant DNA per se does not produce the enzyme, the production of the enzyme encoded by the DNA is induced by introducing the recombinant DNA into a host, which is incapable of producing the enzyme but replicable with relative ease, to form a transformant, and culturing the transformant to produce the enzyme.

The transformant according to the present invention produces the enzyme when cultured.

The recombinant enzyme according to the present invention acts on reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher to form non-reducing saccharides having trehalose structure as an end unit.

The culture of the transformant according to the present invention yields a desired amount of the enzyme with relative ease.

The conversion method according to the present invention converts reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher into non-reducing saccharides having trehalose structure as an end unit.

The present invention was made based on the finding of a novel enzyme which forms non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher. The enzyme can be obtained from cultures of microorganisms of the species Rhizobium sp. M-11 and Arthrobacter sp. Q36 (the enzymes from Rhizobium sp. M-11 and Arthrobacter sp. Q36 are respectively designated as "enzyme M-11" and "enzyme Q36" hereinafter), and the present inventors isolated the enzyme using a combination of conventional purification methods which mainly includes column chromatography mainly, and examined the properties and features to reveal a polypeptide having the following physicochemical properties:

(1) Action

Forming non-reducing saccharides having trehalose structure as an end unit from reducing saccharides having a degree of glucose polymerization of 3 or higher;

(2) Molecular weight

About 76,000-87,000 daltons on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE);

(3) Isoelectric point

About 3.6-4.6 on isoelectrophoresis;

(4) Optimum temperature

Exhibiting an optimum temperature of around 35°-40° C. when incubated at pH 7.0 for 60 min;

(5) Optimum pH

Exhibiting an optimum pH of around 6.4-7.2 when incubated at 40° C. for 60 min;

(6) Thermal stability

Stable up to a temperature of around 35°-40° C. when incubated at pH 7.0 for 60 min; and

(7) pH Stability

Stable up to a pH of around 5.5-11.0 when incubated at 25° C. for 16 hours.

The experiments, which were conducted to reveal the aforesaid physicochemical properties, are explained in the below:

EXPERIMENT 1 Preparation of purified enzyme

Experiment 1-1

Preparation of enzyme derived from Rhizobium sp. M-11

In 500-ml Erlenmeyer flasks were placed 100 ml aliquots of a liquid culture medium (pH 7.0) containing 2.0 w/v % maltose, 0.5 w/v % peptone, 0.1 w/v % yeast extract, 0.1 w/v % disodium hydrogen phosphate, and 0.1 w/v % potassium dihydrogen phosphate, and the flasks were autoclaved at 120° C. for 20 min to effect sterilization. After cooling the flasks a seed culture of Rhizobium sp. M-11 was inoculated into each liquid culture medium in each flask, followed by the incubation at 27° C. for 24 hours under rotary-shaking conditions. Twenty L of a fresh preparation of the same liquid culture medium was put in a 30-L jar fermentor and sterilized, followed by inoculating one v/v % of the culture obtained in the above into the sterilized liquid culture medium in the jar fermentor, and incubating it at a pH of 6-8 and 30° C. for 24 hours under aeration and agitation conditions.

Thereafter, about 18 L of the resultant culture was subjected to an ultra-high pressure cell disrupting apparatus to disrupt cells, and the resultant suspension was centrifuged to obtain a supernatant, and to about 16 L of which was added ammonium sulfate to give a 20 w/v % saturation, allowed to stand at 4° C. for one hour, and centrifuged to remove sediment. To the resultant supernatant was added ammonium sulfate to give a 60 w/v % saturation, allowed to stand at 4° C. for 24 hours, and centrifuged to collect sediment which was then dissolved in a minimum amount of 10 mM phosphate buffer (pH 7.0). The resultant solution was dialyzed against 10 mM phosphate buffer (pH 7.0) for 24 hours, and centrifuged to remove insoluble substances. The supernatant thus obtained was fed to a column packed with "DEAE-TOYOPEARL®", a product for ion-exchange chromatography commercialized by Tosoh Corporation, Tokyo, Japan, which had been previously equilibrated with 10 mM phosphate buffer (pH 7.0), followed by feeding to the column a linear gradient buffer of sodium chloride ranging from 0M to 0.5M in 10 mM phosphate buffer (pH 7.0). Fractions containing the objective enzyme were collected from the eluate, pooled, dialyzed for 10 hours against 50 mM phosphate buffer (pH 7.0) containing 2M ammonium sulfate, and centrifuged to remove insoluble substances. Thereafter, the resultant supernatant was fed to a column, which had been packed with "BUTYL TOYOPEARL®", a gel for hydrophobic column chromatography commercialized by Tosoh Corporation, Tokyo, Japan, and equilibrated with 50 mM phosphate buffer (pH 7.0) containing 2M ammonium sulfate, followed by feeding to the column a linear gradient buffer of ammonium sulfate ranging from 2M to 0M in 50 mM phosphate buffer (pH 7.0). Fractions containing the objective enzyme were collected from the eluate, pooled, fed to a column packed with "TOYOPEARL® HW-55", a product for gel filtration column chromatography commercialized by Tosoh Corporation, Tokyo, Japan, which had been previously equilibrated with 50 mM phosphate buffer (pH 7.0), followed by feeding to the column 50 mM phosphate buffer (pH 7.0) and collecting fractions containing the objective enzyme. The enzyme thus obtained had a specific activity of about 195 units/mg protein, and the yield was about 220 units per L of the culture.

Throughout the specification the enzyme activity is expressed by the value measured on the following assay: Placing 4 ml of 50 mM phosphate buffer (pH 7.0) containing 1.25 w/v % maltopentaose in a test tube, add one ml of an enzyme solution to the tube, and incubate the resultant solution at 40° C. for 60 min to effect enzymatic reaction. Thereafter, heating the resultant reaction mixture at 100° C. for 10 min to suspend the enzymatic reaction. Diluting the resultant reaction mixture with distilled water by 10 times, and assay the reducing activity on the Somogyi-Nelson's method. One unit activity of the enzyme is defined as the amount of enzyme which reduces the reducing power corresponding to one pmol maltopentaose per min under the same conditions as described above.

Experiment 1-2

Purification of enzyme Q36

Similarly as in Experiment 1-1, a seed culture of Arthrobacter sp.Q36 was cultured, and the resultant culture was treated to obtain a purified enzyme Q36 having a specific activity of about 200 units/mg protein in a yield of about 295 units per L of the dulture.

EXPERIMENT 2 Physicochemical property of enzyme

Experiment 2-1

Action

To 50 mM phosphate buffer (pH 7.0) containing 20 w/v % of glucose, maltose, maltotriose, maltotetraose, maltopentaose, maltohexaose or maltoheptaose as a substrate was added 2 units/g substrate, d.s.b., of the purified enzyme M-11 or enzyme Q36 obtained in Experiment 1, and the mixture was enzymatically reacted at 40° C. for 48 hours. The reaction mixture was desalted in usual manner, fed to "WB-T-330", a column for high-performance liquid chromatography (HPLC) commercialized by Tosoh Corporation, Tokyo, Japan, followed by feeding to the column distilled water at a flow rate of 0.5 ml/min at ambient temperature to separate saccharides contained in the reaction mixture while monitoring the saccharide concentration of the eluate with "MODEL RI-8012", a differential refractometer commercialized by Wako Pure Chemical Industries, Ltd., Tokyo, Japan. The saccharide composition of the reaction mixture was given in Table 1 or 2. In the table, the symbols "P1" to "P5" were named for the formed saccharides in the order from the smallest one to the largest one in terms of their degrees of glucose polymerization.

                  TABLE 1     ______________________________________                Saccharide in                            Elution time                                      Composition     Substrate  reaction mixture                            (min)     (%)     ______________________________________     Glucose    Glucose     33.4      100.0     Maltose    Maltose     28.5      100.0     Maltotriose                P1          23.3      35.0                + Maltotriose                            25.9      65.0     Maltotetraose                P2          21.6      85.6                + Maltotetraose                            24.1      14.4     Maltopentaose                P3          19.7      92.7                + Maltopentaose                            22.6      7.3     Maltohexaose                P4          18.7      93.5                + Maltohexaose                            21.4      6.5     Maltoheptaose                P5          17.8      93.4                + Maltoheptaose                            21.0      6.7     ______________________________________

                  TABLE 2     ______________________________________                Saccharide in                            Elution time                                      Composition     Substrate  reaction mixture                            (min)     (%)     ______________________________________     Glucose    Glucose     33.4      100.0     Maltose    Maltose     28.5      100.0     Maltotriose                P1          23.3      35.5                + Maltotriose                            25.9      64.5     Maltotetraose                P2          21.6      85.8                + Maltotetraose                            24.1      14.2     Maltopentaose                P3          19.7      92.9                + Maltopentaose                            22.6      7.1     Maltohexaose                P4          18.7      93.2                + Maltohexaose                            21.4      6.7     Maltoheptaose                P5          17.8      93.1                + Maltoheptaose                            21.0      6.9     ______________________________________

As is evident from the results in Table 1 and 2, the enzymes M-11 and Q36 newly formed saccharides from reducing saccharides having a degree of glucose polymerization of 3 or higher such as maltotriose, maltotetraose, maltopentaose, maltohexaose and maltoheptaose, but not from those having a degree of glucose polymerization less than 3 such as glucose and maltose. In the enzymatic reaction, the newly formed saccharides were P1 to P5, and the total yield of the saccharides P2 to P5 was as high as 85 w/w % or more, d.s.b.

To separate the saccharides P1 to P5, 3 jacketed stainless steel columns, having an inner diameter of 2.0 cm and a length of one m, were packed with "XT-1016, Na⁺ ", a strong-acid cation exchange resin commercialized by Tokyo Organic Chemical Industries, Ltd., Tokyo, Japan, and cascaded in series. The reaction mixture containing any one of saccharides P1 to P5 was separatory applied to the columns at an inner column temperature of 55° C., followed by applying to the columns with 55° C. distilled water at a flow rate of SV (space velocity) 0.13. After examining the saccharide composition of the resultant eluate, a fraction containing 97 w/w % or more, d.s.b., of any one of saccharides P1 to P5 was recovered and pulverized in vacuo. No substantial reducing power was detected in the purified saccharides P1 to P5 on the Somogyi-Nelson's method.

To identify the saccharides P1 to P5, 50 mg one of which was weighed, dissolved in one ml of 50 mM acetate buffer (pH 4.5), and mixed with one unit of glucoamylase, followed by incubating the mixture at 40° C. for 6 hours. High-performance liquid chromatography analysis on the resultant reaction mixture detected glucose and trehalose as shown in Tables 3 and 4. When the saccharides P1 to P5 were subjected to the action of β-amylase, the saccharides P1 and P2 were not hydrolyzed by β-amylase, but the saccharides P3, P4 and P5 were respectively hydrolyzed into one mole of maltose, P2 and one mole of maltose, and P1 and 2 moles of maltose.

                  TABLE 3     ______________________________________               Glucose     Trehalose     Substrate (%)         (%)      Molar ratio*     ______________________________________     P1        36.2        63.8     1.07     P2        52.0        48.0     2.06     P3        61.4        38.6     3.02     P4        68.3        31.7     4.09     P5        72.9        27.1     5.11     ______________________________________      Note: The molar ratios as indicated with the symbol "*" are values      calculated as moles of glucose against one mole of trehalose.

                  TABLE 4     ______________________________________               Glucose     Trehalose     Substrate (%)         (%)      Molar ratio*     ______________________________________     P1        36.0        64.0     1.07     P2        51.5        48.5     2.02     P3        61.6        38.4     3.05     P4        68.1        31.9     4.06     P5        72.5        27.5     5.01     ______________________________________      Note: The molar ratios as indicated with the symbol "*" are values      calculated as moles of glucose against one mole of trehalose.

The results in Tables 3 and 4 strongly show that the saccharides P1 to P5 consist of one mole of trehalose and 1 to 5 moles of glucose. Because of the facts that glucoamylase specifically hydrolyzes the α-1,4 and α-1,6 linkages in maltooligosaccharides and that β-amylase hydrolyzes the α-1,4 linkage in maltooligosaccharides from their end terminals by maltose units, it is estimated that the saccharides P1 to P5 have a structure consisting of glucose or maltooligosaccharide having a degree of glucose polymerization of 2 to 5, both of which have a trehalose residue at their end terminals.

The total analysis of the above results identifies the saccharides P1 to P5 as α-glucosyl trehalose, α-maltosyl trehalose, α-maltotriosyl trehalose, α-maltotetraosyl trehalose and α-maltopentaosyl trehalose respectively, and this demonstrates that the enzymes have an activity of forming non-reducing saccharides having trehalose structure as an end unit from reducing saccharides having a degree of glucose polymerization of 3 or higher.

Experiment 2-2

Molecular weight

In accordance with the method reported by U. K. Laemmli in Nature, Vol.227, pp.680-685 (1970), the purified enzymes M-11 and Q36 in Experiment 1 were respectively electrophoresed on sodium dodecyl polyacrylamide gel electrophoresis to give a single protein band at a position corresponding to about 76,000-87,000 daltons. The marker proteins used in this experiment were myosin (MW=200,000 daltons), β-galactosidase (MW=116,250 daltons), phosphorylase B (MW=97,400 daltons), serum albumin (MW=66,200 daltons) and ovalbumin (MW=45,000 daltons).

Experiment 2-3

Isoelectric point

The purified enzymes M-11 and Q36 obtained in Experiment 1 gave an isoelectric point of about 3.6-4.6 on isoelectrophoresis respectively.

Experiment 2-4

Optimum temperature

The optimum temperature of the purified enzymes M-11 and Q36 obtained in Experiment 1 was about 35°-40° C. as shown in FIG. 1 or 2 when incubated in usual manner in 50 mM phosphate buffer (pH 7.0) for 60 min.

Experiment 2-5

Optimum pH

The optimum pH of the purified enzymes M-11 and Q36 obtained in Experiment 1 was about 6.4-7.2 as shown in FIG. 3 or 4 when experimented in usual manner by incubating them at 40° C. for 60 min in 50 mM acetate buffer, phosphate buffer or sodium carbonate-sodium hydrogen carbonate buffer having different pHs.

Experiment 2-6

Thermal stability

The purified enzymes M-11 and Q36 obtained in Experiment 1 were stable up to a temperature of about 35°-40° C. as shown in FIGS. 5 and 6 when experimented in usual manner by incubating them in 50 mM phosphate buffer (pH 7.0) for 60 min.

Experiment 2-7

pH Stability

The purified enzymes M-11 and Q36 obtained in Experiment 1 were stable up to a pH of about 5.5-11.0 as shown in FIGS. 7 and 8 when experimented in usual manner by incubating them at 25° C. for 16 hours in 50 mM acetate buffer, phosphate buffer or sodium carbonate-sodium hydrogen carbonate buffer having different pHs.

Experiment 2-8

Amino acid sequence containing the N-terminal

The amino acid sequence containing the N-terminal of the purified enzyme M-11 obtained in Experiment 1 was analyzed on "MODEL 470 A", a gas-phase protein sequencer commercialized by Applied Biosystems, Inc., Foster City, USA, revealing that enzyme M-11 has an amino acid sequence as shown in SEQ ID NO:12.

The amino acid sequence containing the N-terminal of the purified enzyme Q36 was similarly analyzed as in enzyme M-11 revealing that it has an amino acid sequence as shown in SEQ ID NO:13.

Experiment 2-9

Partial amino acid sequence

An adequate amount of the purified enzyme M-11 obtained in Experiment 1-1 was weighed, dialyzed against 10 mM Tris-HCl buffer (pH 9.0) at 4° C. for 18 hours, and admixed with 10 mM Tris-HCl buffer (pH 9.0) to give a concentration of about one mg/ml of the enzyme. About one ml of the resultant solution was placed in a container, admixed with 10 μg lysyl endopeptidase, and incubated at 30° C. for 22 hours to partially hydrolyze the enzyme. The resultant hydrolysate was applied to "CAPCELL-PAK C18", a column for reverse-phase high-performance liquid chromatography commercialized by Shiseido Co., Ltd., Tokyo, Japan, which had been previously equilibrated with 0.1 v/v % trifluoroacetate containing 16 v/v % aqueous acetonitrile, followed by feeding to the column 0.1 v/v % trifluoroacetate at a flow rate of 0.9 ml/min while increasing the concentration of acetonitrile from 16 to 64 v/v % to separatory collect fractions containing a peptide fragment about 28 min or 40 min after the initiation of feeding (the peptide fragments were respectively named "peptide fragment A" and "peptide fragment B"). Fractions containing the peptide fragment A or B were separatory pooled, dried in vacuo, and dissolved in 0.1 v/v % trifluoroacetate containing 50 v/v % aqueous acetonitrile. Similarly as in Experiment 2-8, the peptide fragments A and B were analyzed and revealed to have an amino acid sequence as shown in SEQ ID NO:14 and an amino acid sequence as shown in SEQ ID NO:15.

Similarly as in enzyme M-11, enzyme Q36 obtained in Experiment 1-2 was partially hydrolyzed, and the resultant was fed to "μBONDAPAK C18", a column for reverse-phase high-performance liquid chromatography commercialized by Japan Millipore Ltd., Tokyo, Japan, followed by feeding to the column 0.1 v/v % trifluoroacetate containing aqueous acetonitrile ranging from a concentration of 24 v/v % to 44 v/v % at a flow rate of 0.9 ml/ml. Fractions containing a peptide fragment eluted about 22 min or about 40 min after the initiation of feeding (the fractions were respectively called "peptide fragment C" and "peptide fragment D" hereinafter) were respectively collected, pooled, dried in vacuo, and dissolved in 0.1 v/v % trifluoroacetate containing 50 v/v % aqueous acetonitrile. Analyses of the peptide fragments C and D conducted as in a similar fashion as described above revealed that they have amino acid sequences as shown in SEQ ID NOs:16 and 17, respectively.

No enzyme having these physicochemical properties has been known, and the conclusion is that it is a novel substance. Referring to Rhizobium sp. M-11, it is a microorganism which was isolated from a soil of Okayama-city, Okayama, Japan, deposited on Dec. 24, 1992, in National Institute of Bioscience and Human-Technology Agency of Industrial Science and Technology, Tsukuba, Ibaraki, Japan, and accepted under the accession number of FERM BP-4130, and it has been maintained by the institute. Arthrobacter sp. Q36 is a microorganism which was isolated from a soil of Soja-city, Okayama, Japan, deposited on Jun. 3, 1993, in the same institute, and accepted under the accession number of FERM BP-4316, and it has been maintained by the institute. Japanese Patent Application No.349,216/93 applied by the same applicant discloses the properties and features of the non-reducing saccharide-forming enzyme as well as the detailed bacteriological properties of these microorganisms.

The present inventors energetically screened a chromosomal DNA of Rhizobium sp. M-11 by using an oligonucleotide as a probe which had been chemically synthesized based on the partial amino acid sequence of enzyme M-11 as revealed in Experiment 2-9, and found a DNA fragment which consists of 2,316 base pairs having a base sequence as shown in the following SEQ ID NO:1 which initiates from the 5'-terminus. The decoding of the base sequence revealed that the enzyme consists of 772 amino acids as shown in SEQ ID NO:2.

Similarly as in enzyme M-11, a chromosomal DNA of enzyme Q36 was-screened by using an oligonucleotide as a probe which had been chemically synthesized based on a partial amino acid sequence of enzyme Q36, and this yielded a DNA fragment having a base sequence consisting of 2,325 base pairs from the 5'-terminus as shown in SEQ ID NO:3. The base sequence was decoded to reveal that enzyme Q36 consists of 775 amino acids and has a partial amino acid sequence containing the N-terminal as shown in SEQ ID NO:4.

The sequential experimental steps used to reveal the base sequence and amino acid sequence as shown in SEQ ID NOs:1 to 4 are summarized as below:

(1) The enzyme was isolated from a culture of a donor microorganism and highly purified. The purified enzyme was partially hydrolyzed with protease, and the resultant 2 different types of peptide fragments were isolated and determined their amino acid sequences;

(2) Separately, a chromosomal DNA was isolated from a donor microorganism's cell, purified and partially digested by a restriction enzyme to obtain a DNA fragment consisting of about 3,000-7,000 base pairs. The DNA fragment was ligated by DNA ligase to a plasmid vector, which had been previously cut with a restriction enzyme, to obtain a recombinant DNA;

(3) The recombinant DNA was introduced into Escherichia coli to obtain transformants, and from which an objective transformant containing a DNA encoding the enzyme was selected by the colony hybridization method using as a probe an oligonucleotide which had been chemically synthesized based on the aforesaid partial amino acid sequence; and

(4) The recombinant DNA was obtained from the transformant and annealed with a primer, followed by allowing a DNA polymerase to act on the resultant to extend the primer, and determining the base sequence of the resultant complementary chain DNA by the dideoxy chain termination method. The comparison of an amino acid sequence deduced from the determined base sequence with the aforesaid amino acid sequence confirmed that the base sequence encodes the enzyme.

As is in above, the enzyme, which forms non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher, is an enzyme which was found as a result of the present inventors' long-term research. The enzyme has distinct physicochemical properties from those of other conventional enzymes. The present invention is to produce the enzyme by applying recombinant DNA technology. The recombinant DNA, and its preparation and uses are explained in detail with reference to the examples.

The recombinant enzyme as referred to in the invention means all enzymes which are preparable by recombinant DNA technology and capable of forming non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher. Generally, the recombinant enzyme according to the present invention has a revealed amino acid sequence, and, as an example, the amino acid sequence, which initiates from the N-terminal as shown in SEQ ID NO:2 or 4, and homologous ones to it can be mentioned. Variants having amino acid sequences homologous to the one as shown in SEQ ID NO:2 or 4 can be obtained by replacing one or more amino acids in SEQ ID NO:2 or 4 with other amino acids without substantially altering the inherent action of the enzyme. Although even when used the same DNA is and depending on the hosts into which the DNA is introduced, ingredients and components of nutrient culture media for culturing transformants, and their cultivation temperature and pH, modified enzymes may be produced which have amino acid sequences similar to that of SEQ ID NO:2 or 4 as well as having an enzymatic action of the enzyme encoded by the DNA but deleted in one or more amino acids located near the N-terminal of the amino acid sequence as shown in SEQ ID NO:2 or 4 and/or having one or more amino acids newly added after the DNA expression to the N-terminal by the modification of intracellular enzymes of hosts. The recombinant enzyme can be obtained from cultures of transformants containing a specific DNA. Examples of such a transformant used in the invention can be prepared by introducing into hosts a DNA having either the base sequence which initiates from the N-terminal or a homologous base sequence to it or a complementary base sequence to them. Such a base sequence may be prepared by replacing one or more bases thereof without altering the amino acid sequence encoded thereby by using the degeneracy of genetic code. Needless to say, one or more bases in the base sequence, which encodes the enzyme or their variants, can be readily replaced with other bases to allow the DNA to actually express the enzyme production in hosts.

The DNA usable in the present invention includes any one of those derived from natural resources and artificially synthesized ones as long as they have such an aforementioned base sequence. The natural resources for the DNA according to the present invention are, for example, microorganisms of the genera Rhizobium, Arthrobacter, Brevibacterium, Flavobacterium, Micrococcus, Curtobacterium, Mycobacterium and Terrabacter, i.e. Rhizobium sp. M-11 (FERM BP-4130), Arthrobacter sp. Q36 (FERM BP-4316), Brevibacterium helovolum (ATCC 11822), Flavobacterium aquatile (IFO 3772), Micrococcus luteus (IFO 3064), Micrococcus roseus (ATCC 186), Curtobacterium citreum (IFO 15231), Mycobacterium smegmatis (ATCC 19420) and Terrabacter tumescens (IFO 12960) from which genes containing the present DNA can be obtained. The aforementioned microorganisms can be inoculated in nutrient culture media and cultured for about 1-3 days under aerobic conditions, and the resultant cells were collected from the cultures and subjected to ultrasonication or treated with a cell-wall lysis enzyme such as lysozyme or β-glucanase to extract genes containing the present DNA. In this case, a proteolytic enzyme such as protease can be used along with the cell-wall lysis enzyme, and, in the case of treating the cells with an ultrasonic disintegrator, they may be treated in the presence of a surfactant such as sodium dodecyl sulfate (SDS) or may be treated with freezing and thawing. The objective DNA is obtainable by treating the resultant cell extract with phenol extraction, alcohol sedimentation, centrifugation, protease treatment and/or ribonuclease treatment used in general in this field. To artificially synthesize the present DNA, it can be chemically synthesized by using the base sequence as shown in SEQ ID NO:1 or 3, or can be obtained in a plasmid form by inserting a DNA which encodes the amino acid sequence as shown in SEQ ID NO:2 or 4 into an appropriate self-replicable vector to obtain a recombinant DNA, introducing the recombinant DNA into an appropriate host to obtain a transformant, culturing the transformant, separating the proliferated cells from the resultant culture, and collecting plasmids containing the DNA from the cells.

Such a recombinant DNA is generally introduced into hosts in a recombinant DNA form. Generally, the recombinant DNA contains the aforesaid DNA and a self-replicable vector, and it can be prepared with a relative easiness by recombinant DNA technology in general when the material DNA is in hand. Examples of such a vector are plasmid vectors such as pBR322, pUC18, Bluescript II SK(+), pUB110, pTZ4, pC194, pHV14, TRp7, TEp7, pBS7, etc.; and phage vectors such as λgt. λC, λgt. λB, ρ11, φ1, φ105, etc. Among these plasmid- and phage-vectors, pBR322, pUC18, Bluescript II SK(+), λgt. λC and λgt. λB are satisfactorily used when the present DNA needs to be expressed in Escherichia coli, while pUB110, pTZ4, pC194, ρ11, φ1 and φ105 are satisfactorily used to express the DNA in microorganisms of the genus Bacillus. The plasmid vectors pHV14, TRp7, TEp7 and pBS7 are advantageously used when the recombinant DNA is allowed to grow in 2 or more hosts.

The methods used to insert the present DNA into such a vector in the invention may be conventional methods in this field. A gene containing the present DNA and a self-replicable vector are first digested by a restriction enzyme and/or ultrasonic disintegrator, then the resultant DNA fragments and vector fragments are ligated. To digest DNAs and vectors, restriction enzymes which specifically act on nucleotides, particularly, type II restriction enzymes, more particularly Sau 3AI, Eco RI, Hind III, Bam HI, Sal I, Xba I, Sac I, Pst I, etc., facilitate the ligation of the DNA fragments and vector fragments. To ligate the DNA fragments with vector fragments, they are annealed if necessary, then subjected to the action of a DNA ligase in vivo or in vitro. The recombinant DNA thus obtained is replicable without substantial limitation by introducing it into appropriate hosts, and culturing the resultant transformants.

The recombinant DNA thus obtained can be introduced into appropriate host microorganisms including Escherichia coli and those of the genus Bacillus as well as actinomyces and yeasts. In the case of using Escherichia coli as a host, the DNA can be introduced thereinto by culturing the host in the presence of the recombinant DNA and calcium ion, while in the case of using a microorganism of the genus Bacillus as a host the competent cell method and the colony hybridization method can be employed. Desired transformants can be cloned by the colony hybridization method or by culturing a variety of transformants in nutrient culture media containing reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher, and selecting the objective transformants which form non-reducing amylaceous saccharides having trehalose structure as an end unit from the reducing amylaceous saccharides.

The transformants thus obtained extracellularly produce the objective enzyme when cultured in nutrient culture media. Generally, liquid culture media in general supplemented with carbon sources, nitrogen sources and minerals, and, if necessary, further supplemented with small amounts of amino acids and vitamins can be used in the invention. Examples of the carbon sources are saccharides such as starch, starch hydrolysate, glucose, fructose and sucrose. Examples of the nitrogen sources are organic- and inorganic-substances containing nitrogen such as ammonia, ammonium salts, urea, nitrate, peptone, yeast extract, defatted soy been, corn steep liquor, and beef extract. Cultures containing the objective enzyme can be prepared by inoculating the transformants into nutrient culture media, and incubating them at a temperature of 25°-65° C. and a pH of 2-8 for about 1-6 days under aerobic conditions by aeration and agitation. Such a culture can be used intact as an enzyme agent, and, usually, it may be disrupted prior to use with ultrasonic disintegrator and/or cell-wall lysis enzymes, followed by separating the enzyme from the intact cells and cell debris by filtration and/or centrifugation and purifying the enzyme. The methods to purify the enzyme include conventional ones in general. From cultures intact cells and cell debris are eliminated and subjected to one or more methods such as concentration, salting out, dialysis, separatory sedimentation, gel filtration chromatography, ion-exchange chromatography, hydrophobic chromatography, affinity chromatography, gel electrophoresis and isoelectric point electrophoresis.

As described above, the recombinant enzyme according to the present invention has a specific feature of forming non-reducing saccharides having trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher. The formed non-reducing saccharides have a satisfactorily mild and high-quality sweetness as well as an adequate viscosity and moisture-retaining ability, and, as a great advantageous feature, they can sweeten food products without fear of causing coloration and deterioration because they do not have a reducing residue within their molecule. By using these features a variety of amylaceous saccharides, which have been put aside because of their reducibilities, can be converted into saccharides having a satisfactory handleability and usefulness but having substantially no or extremely-reduced reducibility.

The conversion method is in more detail, where reducing starch hydrolysates, which are obtainable by partially hydrolyzing amylaceous saccharides such as starch, amylopectin and amylose by acids and/or amylases, can be usually used as the substrate for the present recombinant enzyme. Such a starch hydrolysate can be obtained by conventional methods generally used in the art, and examples thereof include one or more maltooligosaccharides having a degree of glucose polymerization of 3 or higher such as maltotriose, maltotetraose, maltopentaose, maltohexaose and maltoheptaose. As described in "Handbook of Amylases and Related Enzymes", 1st edition, edited by The Amylase Research Society of Japan, published by Pergamon Press plc, Oxford, England (1988), α-amylase, maltotetraose-forming amylase, maltopentaose-forming amylase and maltohexaose-forming amylase are especially useful to prepare the reducing amylaceous saccharides used in the invention, and, the use of any one of these amylases readily yields amylaceous saccharide mixtures rich in reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher in a considerably-high yield. If necessary, the use of amylases and starch debranching enzymes such as pullulanase and isoamylase can increase the yield of the reducing amylaceous saccharides used as the substrate for the present recombinant enzyme.

In the conversion method according to the present invention, the present recombinant enzyme is allowed to coexist in an aqueous solution is then allowed containing one or more of the aforesaid reducing amylaceous saccharides as a substrate, and allowing the solution to enzymatically react at a prescribed temperature and pH until a desired amount of the objective reducing amylaceous saccharides is formed. Although the enzymatic reaction proceeds even below a concentration of 0.1 w/v % of a substrate, a higher concentration of 2 w/v %, preferably, 5-50 w/v % of a substrate can be satisfactorily used to apply the present conversion method to an industrial-scale production. The temperature and pH used in the enzymatic reaction are set within the ranges of which do not inactivate the recombinant enzyme and allow the recombinant enzyme to effectively act on substrates, i.e. a temperature up to about 55° C., preferably, a temperature in the range of about 40°-55° C., and a pH of 5-10, preferably, a pH in the range of about 6-8. The amount and reaction time of the present recombinant enzyme are chosen dependently on the enzymatic reaction condition. The enzymatic reaction relatively-highly reduces the reducing power of reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher, and, in the case of maltopentaose, the reducing powder is lowered to about 7% against the original level.

The reaction mixtures obtained by the present conversion reaction can be used intact, and, usually, they are purified prior to use: Insoluble substances are eliminated from the reaction mixtures by filtration and centrifugation, and the resultant solutions are decolored with an activated charcoal, desalted and purified on ion exchangers, and concentrated into syrupy products. Depending on their use, the syrupy products are dried in vacuo and spray-dried into solid products. In order to obtain products which substantially consist of non-reducing saccharides, the aforesaid syrupy products are subjected to one or more methods such as chromatography using an ion exchanger, activated charcoal and silica gel for saccharide separation, separatory sedimentation using alcohol and/or acetone, membrane filtration, fermentation by yeasts, and removal and decomposition of reducing saccharides by alkalis. The methods to treat a large amount of reaction mixture are, for example, fixed bed- or pseudomoving bed-ion exchange column chromatography as disclosed in Japanese Patent Laid-Open Nos. 23,799/83 and 72,598/83, and such a method produces non-reducing saccharide-rich products in an industrial scale and in a considerably-high yield.

The reducing saccharides thus obtained have a wide applicability to a variety of products which are apt to be readily damaged by the reducibility of saccharide sweeteners: For example, they can be satisfactorily used in food products, cosmetics and pharmaceuticals as a sweetener, taste-improving agent, quality-improving agent, stabilizer, filler, excipient and adjuvant. Since the non-reducing saccharides approximately qualitatively form trehalose upon being acted upon by the enzymatic action of a trehalose-releasing enzyme as disclosed in Japanese Patent Application No. 340,343/93, they can be used as an intermediate for the production of trehalose which could not have been readily prepared.

The following examples explain the present invention in more detail, and the recombinant DNA technologies or techniques employed therein are in themselves conventional ones used in the art, for example, those described by J. Sambrook et al. in "Molecular Cloning A Laboratory Manual", 2nd edition, published by Cold Spring Harbor Laboratory Press, USA (1989).

EXAMPLE 1 Preparation of recombinant DNA containing DNA derived from enzyme M-11, and transformant

Example 1-1

Preparation of chromosomal DNA

A seed culture of Rhizobium sp. M-11 was inoculated into bacto nutrient broth medium (pH 7.0), and cultured at 27° C. for 24 hours with a rotary shaker. The cells were separated from the resultant culture by centrifugation, suspended in TES buffer (pH 8.0), admixed with 0.05 w/v % lysozyme, and incubated at 37° C. for 30 min. The resultant was freezed at -80° C. for one hour, admixed with TSS buffer (pH 9.0), heated to 60° C., and admixed with a mixture solution of TES buffer and phenol, and the resultant solution was chilled with ice, followed by centrifugally collecting the precipitated crude chromosomal DNA. To the supernatant was added 2 fold volumes of cold ethanol, and the precipitated crude chromosomal DNA was collected, suspended in SSC buffer (pH 7.1), admixed with 7.5 μg ribonuclease and 125 μg protease, and incubated at 37° C. for one hour. Thereafter, a mixture solution of chloroform and isoamyl alcohol was added to the reaction mixture to extract the objective chromosomal DNA, and admixed with cold ethanol, followed by collecting the formed sediment containing the chromosomal DNA. The purified chromosomal DNA thus obtained was dissolved in SSC buffer (pH 7.1) to give a concentration of about one mg/ml, and the solution was freezed at -80° C.

Example 1-2

Preparation of recombinant DNA pBMT7 and transformant BMT7

About one ml of the purified chromosomal DNA obtained in Example 1-1 was placed in a container, admixed with about 35 units of Sau 3AI, a restriction enzyme, and enzymatically reacted at 37° C. for about 20 min to partially digest the chromosomal DNA, followed by recovering a DNA fragment consisting of about 3,000-7,000 base pairs by sucrose density-gradient ultracentrifugation. One μg of Bluescript II SK(+), a plasmid vector, was provided, subjected to the action of Bam HI, a restriction enzyme, to completely digest the plasmid vector, admixed with 10 μg of the DNA fragment and 2 units of T4 DNA ligase, and allowed to stand at 4° C. overnight to ligate the DNA fragment to the vector fragment. To the resultant recombinant DNA was added 30 μl of "Epicurian Coli® XLI-Blue", competent cell commercialized by Toyobo Co., Ltd., Tokyo, Japan, allowed to stand under ice-chilled conditions for 30 min, heated to 42° C., admixed with SOC broth, incubated at 37° C. for one hour to introduce the recombinant DNA into Escherichia coli.

The resultant transformant was inoculated into agar plate (pH 7.0) containing 50 μg/ml of 5-bromo-4-chloro-3-indolyl-β-galactoside, and cultured at 37° C. for 18 hours, followed by placing a nylon film on the agar plate to fix thereon about 4,400 colonies formed on the agar plate. Based on the amino acid sequence of Pro-Glu-Trp-Glu-Lys located at positions from 17 to 21 in the amino acid sequence of the peptide fragment A as revealed in Experiment 2-9, the base sequence of probe 1 as shown in SEQ ID NO:5 was chemically synthesized, labelled with ³² P, and hybridized with the colonies of transformants fixed on the nylon film, followed by selecting 9 transformants which exhibited a strong hybridization.

The objective recombinant DNA was selected in usual manner from the 9 transformants, and, in accordance with the method described by E. M. Southern in Journal of Molecular Biology, Vol.98, pp.503-517 (1975), hybridized with probe 2 having the base sequence as shown in SEQ ID NO:6 which had been chemically synthesized based on the amino acid sequence of Thr-Glu-Phe-Trp-Asp located at positions from 16 to 20 in the amino acid sequence of the peptide fragment B as revealed in Experiment 2-9, followed by selecting a recombinant DNA which strongly hybridized with probe 2. The recombinant DNA and transformant thus selected were respectively named pBMT7 and BMT7.

The transformant BMT7 obtained in the above was inoculated into L-broth (pH 7.0) containing 100 μg/ml ampicillin, and cultured at 37° C. for 24 hours with a rotary shaker. After completion of the culture, the cells were collected from the culture by centrifugation, and treated with the alkaline method in general to extracellularly extract a recombinant DNA. The resultant DNA was in usual manner purified and analyzed to find that the recombinant DNA pBMT7 consists of about 9,300 base pairs and has a structure expressed by the restriction map as shown in FIG. 9. It was revealed that as shown in FIG. 9 the DNA consisting of 2,316 base pairs encoding enzyme M-11 is located in the downstream near to the digested site by Pst I, a restriction enzyme.

Example 1-3

Production of enzyme by transformant

A liquid medium consisting of 2.0 w/v % maltose, 0.5 w/v v peptone, 0.1 w/v % yeast extract, 0.1 w/v % disodium hydrogen phosphate and 0.1 w/v % potassium dihydrogen phosphate was adjusted to pH 7.0, admixed with 50 μg/ml ampicillin, autoclaved at 120° C. for 20 min, cooled and inoculated with a seed culture of transformant BMT7 obtained in Example 1-2, followed by culturing the transformant at 37° C. for 24 hours with a rotary shaker. The resultant culture was treated with an ultrasonic disintegrator to disrupt cells, and the resultant suspension was centrifuged to remove insoluble substances. The supernatant thus obtained was assayed for the enzyme activity to find that one L of the culture yielded about 3,000 units of the enzyme.

As a control, a seed culture of Escherichia coli XLI-Blue or Rhizobium sp. M-11 was inoculated into a fresh preparation of the same liquid culture medium but free of ampicillin, and, in the case of the culture of Rhizobium sp. M-11, it was cultured and treated similarly as above except that the culturing temperature was set to 30° C. Assaying the resultant activity, one L culture of Rhizobium sp. M-11 yielded about 1,500 units of the enzyme, and the yield was significantly lower than that of transformant BMT7. Escherichia coli XLI-Blue used as a host did not form the enzyme.

Thereafter, the enzyme produced by the transformant BMT7 and purified similarly as in Experiment 1-⁺ 1, was examined on its properties and characteristics. As a result, it was revealed that it has substantially the same physicochemical properties as that of Experiment 2 showing a molecular weight of about 76,000-87,000 daltons on SDS-PAGE and an isoelectric point of about 3.6-4.6 on isoelectrophoresis. The results indicate that the present enzyme can be prepared by recombinant DNA technology, and the yield is significantly increased thereby.

EXAMPLE 2 Preparation of complementary DNA derived from enzyme M-11 and determination of its base sequence and amino acid sequence

Two μg of the recombinant DNA pBMT7 obtained by the method in Example 1-2 was weighed, admixed with 2M aqueous sodium hydroxide solution to effect degeneration, and admixed with an adequate amount of cold ethanol, followed by collecting the resultant sediment containing a template DNA and drying the sediment in vacuo. To the template DNA were added 50 pmole/ml of a chemically synthesized primer 1 having the base sequence as shown in SEQ ID NO:7, and 10 μl of 40 mM Tris-HCl buffer (pH 7.5) containing 20 mM magnesium chloride and 50 mM sodium chloride, and incubated at 65° C. for 2 min to effect annealing, and the mixture was admixed with 2 μl of an aqueous solution containing DATP, dGTP and dTTP in respective amounts of 7.5 μM, 0.5 μl of α-³² P!dCTP (2 mCi/ml), one μl of 0.1M dithiothreitol, and 2 μl of 1.5 units/ml T7 DNA polymerase, followed by incubating the resultant mixture at 25° C. for 5 min to extend the primer 1 from the 5'-terminus to the 3'-terminus. Thus, a complementary chain DNA was formed.

The reaction product containing the complementary chain DNA was divided into quarters, to each of which 2.5 μl of 50 mM aqueous sodium chloride solution containing 80 μM dNTP and 8 μM ddATP, ddCTP, ddGTP or ddTTP was added, and the resultant mixture was incubated at 37° C. for 5 min, followed by suspending the reaction by the addition of 4 μl of 95 v/v % aqueous formamide solution containing 20 mM EDTA, 0.05 w/v % bromophenol blue and 0.05 w/v % xylene cyanol. The reaction mixture was placed in a container, heated in a boiling-water bath for 3 min, placed on a gel containing 6 w/v % polyacrylamide, and electrophoresed by energizing the gel with a constant voltage of about 2,000 volts to separate DNA fragments, followed by fixing the gel in usual manner, drying and subjecting the resultant gel to autoradiography.

Analyses of the DNA fragments separated on the radiogram revealed that the complementary chain DNA contains the base sequence consisting of 2,936 base pairs as shown in SEQ ID NO:10. An amino acid sequence deduced from the base sequence was as shown in SEQ ID NO:10, and it was compared with the amino acid sequence containing the N-terminal and the partial amino acid sequence of enzyme M-11 as shown in SEQ ID NO:12, 14 or 15, and found that the amino acid sequence containing the N-terminal of SEQ ID NO:12 corresponded to the amino acid sequence at positions from 1 to 20 of SEQ ID NO:10, and the partial amino acid sequence of SEQ ID NO:14 or 15 corresponded to the amino acid sequence at positions from 486 to 506 or at positions from 606 to 626 of SEQ ID NO:10. The results indicate that the enzyme produced from Rhizobiuzm sp. M-11 has the amino acid sequence of SEQ ID NO:2, and the enzyme derived from the microorganism is encoded by the DNA having the base sequence as shown in SEQ ID NO:1.

EXAMPLE 3 Preparation of recombinant DNA containing DNA derived from Arthrobacter sp. Q36, and transformant

Example 3-1

Preparation of chromosomal DNA

Similarly as in Example 1-1, a chromosomal DNA was isolated from Arthrobacter sp. Q36, purified and dissolved in SSC buffer (pH 7.1) to give a concentration of about one mg/ml, and the resultant solution was freezed at -80° C.

Example 3-2

Preparation of recombinant DNA pBOT13 and transformant BQT13

The purified chromosomal DNA obtained in Example 3-1 was partially digested similarly as in Example 1-2, followed by recovering a DNA fragment consisting of about 3,000-6,000 base pairs by sucrose density gradient ultracentrifugation. The DNA fragment was ligated to a lysate of Bluescript II SK(+) which had been treated with Bam HI similarly as in Example 1-2, and the resultant recombinant DNA was introduced into Escherichia coli XLI-Blue. The transformants thus obtained were cultured similarly as in Example 1-2 in an agar plate containing 5-bromo-4-chloro-3-indolyl-β-D-galactoside, and the resultant about 4,500 colonies were fixed on a nylon film, while probe 3 having the base sequence as shown in SEQ ID NO:8 was chemically synthesized based on the amino acid sequence as expressed by Phe-Asp-Val-Asp-Trp-Asp, which are located at positions from 11 to 16 in the amino acid sequence of the peptide fragment D as shown in SEQ ID NO:17, labelled with ³² P, and hybridized with transformant colonies which had been fixed on the nylon film, followed by selecting 8 transformants which strongly hybridized with probe 3.

Similarly as in Example 1-2, the objective recombinant DNA was selected from the 8 transformants, and hybridized with probe 4 having the base sequence as shown in SEQ ID NO:9 which had been chemically synthesized based on the amino acid sequence located at positions from 16 to 20, i.e. Thr-Glu-Phe-Trp-Asp, in SEQ ID NO:16, followed by selecting a recombinant DNA which strongly hybridized with probe 4. The recombinant DNA and transformant thus selected were respectively named pBQT13 and BQT13.

The transformant BQT13 was inoculated into L-broth containing ampicillin, and cultured similarly as in Example 3-2, and the proliferated cells were collected from the resultant culture, and from which a recombinant DNA was extracted, purified and analyzed to reveal that the recombinant pBQT13 consists of about 7,200 base pairs and has a structure expressed by the restriction map as shown in FIG. 10. As shown in FIG. 3, it was reveal that the DNA, which consists of 2,325 base pairs and encodes the DNA of enzyme Q36, is located in the downstream near the cleavage site of Xmn I.

Example 3-3

Production of enzyme by transformant BOT13

A liquid culture medium consisting of 2.0 w/v % maltose, 0.5 w/v % peptone, 0.1 w/v % yeast extract, 0.1 w/v % disodium hydrogen phosphate and 0.1 w/v % potassium dihydrogen phosphate was adjusted to pH 7.0, admixed with 50 μg/ml ampicillin, autoclaved at 120° C. for 20 min, cooled and inoculated with a seed culture of the transformant BQT13 obtained in Example 3-2, followed by culturing the transformant at 37° C. for 24 hours by a rotary shaker. The resultant culture was treated with an ultrasonic disintegrator to disrupt cells, and the resultant suspension was centrifuged to remove insoluble substances. The supernatant thus obtained was assayed for the enzyme activity to find that one L of the culture yielded about 2,450 units of the enzyme.

As a control, Escherichia coli XLI-Blue or Arthrobacter sp. Q36 was inoculated in a fresh preparation of the same liquid culture medium but free of ampicillin, and cultured and treated similarly as above except that the culturing temperature was set to 30° C. The assay of the activity of the resultants showed that one L of the culture of Arthrobacter sp. Q36 yielded about 1,200 units of the enzyme, a level which was significantly lower than that of the transformant BQT13. Escherichia coli XLI-Blue used as a host did not form the enzyme.

Thereafter, the enzyme produced by the transformant BMT7 was purified similarly as in Experiment 1-1, and examined on the properties and characteristics. As a result, it was revealed that it has substantially the same physicochemical properties as shown in Experiment 2 of a molecular weight of about 76,000-87,000 daltons on SDS-PAGE and an isoelectric point of about 3.6-4.6 on isoelectrophoresis.

The results indicate that the enzyme can be prepared by recombinant DNA technology, and the yield might be significantly increased thereby.

EXAMPLE 4 Preparation of complementary chain DNA derived from Arthrobacter sp. Q36, and determination of its base sequence and amino acid sequence

The recombinant DNA pBQT13 obtained in Example 3-2 was similarly treated as in Example 2 to form a template DNA which was then annealed together with the primer 1, followed by allowing T7 DNA polymerase to act on the resultant to extend the primer 1 from the 5'-terminus to 3'-terminus to obtain a complementary chain DNA. Similarly as in Example 2, the complementary chain DNA was subjected to the dideoxy chain terminator method to analyze DNA fragments isolated on a radiogram. The result revealed that the complementary chain DNA contained a base sequence consisting of 3,073 base pairs and an amino acid sequence deduced from the base sequence were as shown in SEQ ID NO:11. The amino acid sequence was compared with respect to the amino acid sequence containing the N-terminal and the partial amino acid sequence of SEQ ID NO:13, 16 or 17, and found that the amino acid sequence containing the N-terminal of SEQ ID NO:13 corresponded to that located at positions from 1 to 20 in SEQ ID NO:11, and the partial amino acid sequence of SEQ ID NO:16 and 17 corresponded to the amino acid sequence located at positions from 606 to 625 or from 110 to 129 in SEQ ID NO:11. The results indicate that enzyme Q36 has the amino acid sequence of SEQ ID NO:4, and it is encoded by the DNA having the base sequence as shown in SEQ ID NO:3.

EXAMPLE 5 Preparation of recombinant enzyme

In 500-ml Erlenmeyer flasks were placed 100 ml aliquots of a liquid culture medium (pH 7.0) consisting of 2.0 w/v % maltose, 0.5 w/v % peptone, 0.1 w/v % yeast extract, 0.1 w/v % disodium hydrogen phosphate and 0.1 w/v % potassium dihydrogen phosphate, and to each flask was added 50 μg/ml ampicillin and autoclaved at 120° C. for 20 min. Thereafter, the flasks were cooled and inoculated with the transformant BMT7 obtained in Example 1-2, followed by culturing the transformant at 27° C. for 24 hours by a rotary shaker. Apart from this, 18 L of a fresh preparation of the same liquid culture medium was placed in an Erlenmeyer flask, admixed with 50 μg/ml ampicillin, sterilized at 120° C. for 20 min, cooled and inoculated with one v/v % of the seed culture obtained in the above, followed by the culture at 37° C. for 24 hours under aeration and agitation conditions. The resultant culture was treated with an ultrasonic disintegrator to disrupt cells, and the resultant suspension was centrifuged to remove insoluble substances. The supernatant thus obtained was assayed for the enzyme activity to show that one L of the culture yielded about 3,000 units of the enzyme. The supernatant was purified by the method in Experiment 1-1 to obtain an about 50 ml aqueous solution containing about 135 units/ml of a recombinant enzyme having a specific activity of about 200 units/mg protein.

EXAMPLE 6 Preparation of recombinant enzyme

Recombinant BQT13 obtained by the method in Example 3-2 was cultured similarly as in Example 5, and the resultant culture was treated with an ultrasonic integrator to disrupt cells. The resultant suspension was centrifuged to remove insoluble substances, and the resultant supernatant was assayed for the enzyme activity to reveal an enzyme production of about 2,450 units per L of the culture. The supernatant was purified by the method in Experiment 1-1 to obtain an approximately 45 ml aqueous solution containing about 120 units/ml of a recombinant enzyme having a specific activity of about 200 units/mg protein.

EXAMPLE 7 Conversion of starch hydrolysate by recombinant enzyme

A potato starch was suspended in water to give a 6 w/w % suspension which was then autoclaved at 120° C. for 10 min to gelatinize the starch. The gelatinized starch was rapidly cooled to 50° C., adjusted to a pH of about 4.5, admixed with 2,500 units/g starch, d.s.b., of an isoamylase specimen commercialized by Hayashibara Biochemical Laboratories, Inc., Okayama, Japan, and enzymatically reacted at 50° C. for 20 hours. The reaction mixture was adjusted to pH 6.0, autoclaved at 120° C. for 10 min to inactivate the remaining enzyme, rapidly cooled to 45° C., admixed with 150 units/g starch, d.s.b., of "TERMAMYL 60L", an α-amylase specimen commercialized by Novo Nordisk Bioindustri A/S, Copenhagen, Denmark, and enzymatically reacted at 45° C. for 24 hours to obtain a reaction mixture containing reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher such as maltotriose, maltotetraose and maltopentaose. The reaction mixture was autoclaved at 120° C. for 20 min to inactivate the remaining enzyme, rapidly cooled to 45° C., admixed with one unit/g starch, d.s.b., of the recombinant enzyme obtained in Example 5, and enzymatically reacted at 45° C. for 96 hours. The resultant reaction mixture was heated at 96° C. for 10 min to inactivate the remaining enzyme, cooled and filtered, and the resultant filtrate was in usual manner decolored with an activated charcoal, desalted and purified by an ion exchanger and concentrated to obtain an about 70 w/w % syrup, d.s.b., in a yield of about 91%, d.s.b.

Analysis of the syrup conducted by the method of Experiment 2-1 revealed that it had a DE (dextrose equivalent) of 18.7 and contained as a main component, on a dry solid basis, 8.4 w/w % α-glucosyl trehalose, 5.6 w/w % α-maltosyl trehalose, 37.9 w/w % α-maltotriosyl trehalose, and that the greater part of the aforesaid reducing saccharides were converted into their corresponding non-reducing saccharides. The product, having a mild and moderate sweetness as well as an adequate viscosity and moisture-retaining ability, can be satisfactorily used in food products, cosmetics and pharmaceuticals as a sweetener, taste-improving agent, taste-improving agent, quality-improving agent, stabilizer, filler, excipient and adjuvant. The product contains non-reducing saccharides in a relatively-high content, so it can be also used as an intermediate for preparing trehalose.

EXAMPLE 8 Conversion of starch hydrolysate by recombinant enzyme

Potato starch was suspended in water to give a concentration of 33 w/w %, d.s.b., and the suspension was admixed with 0.1 w/w % calcium carbonate, d.s.b. The resultant suspension was admixed with 0.2 w/w % per g starch, d.s.b., of "TERMAMYL 60L", an α-amylase specimen commercialized by Novo Nordisk Bioindustri A/S, Copenhagen, Denmark, and enzymatically reacted at 95° C. for 15 min. The reaction mixture was autoclaved at 120° C. for 10 min to inactivate the remaining enzyme, rapidly cooled, admixed with 5 units/g starch, d.s.b., of a maltotetraose-forming amylase derived from Pseudomonas stutzeri as disclosed in Japanese Patent Laid-Open No. 240,784/88, and enzymatically reacted at 55° C. for 6 hours. Thereafter, the resultant reaction mixture was admixed with 30 units/g starch, d.s.b., of "α-amylase 2A", an α-amylase specimen commercialized by Ueda Chemical Co., Ltd., Osaka, Japan, and enzymatically reacted at 65° C. for 4 hours to form about 50 w/w %, d.s.b., of reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher such as maltotriose, maltotetraose and maltopentaose. The resultant mixture was autoclaved at 120° C. for 10 min to inactivate the remaining enzyme, rapidly cooled to 45° C., adjusted to pH 6.5, admixed with 2 units/g amylaceous saccharide, d.s.b., of the recombinant enzyme obtained in Example 5, and enzymatically reacted at 45° C. for 64 hours. The reaction mixture thus obtained was heated at 95° C. for 10 min to inactivate the remaining enzyme, cooled, filtered, decolored in usual manner with an activated charcoal, desalted and purified with an ion exchanger, and concentrated to obtain a syrupy product with a concentration of about 70 w/w %, d.s.b., in a yield of about 90% against the material starch, d.s.b.

Analysis of the syrupy product by the method in Experiment 2-1 revealed that it had a DE of 10.5 and contained as a main component 3.8 w/w % α-glucosyl trehalose, 43.8 w/w % α-maltosyl trehalose, and 1.2 w/w % α-maltotriosyl trehalose, d.s.b., and that most of the reducing amylaceous saccharides contained therein were converted into their corresponding non-reducing saccharides. The product, having a mild and moderate sweetness as well as an adequate viscosity and moisture-retaining ability, can be satisfactorily used in food products, cosmetics and pharmaceuticals as a sweetener, taste-improving agent, quality-improving agent, stabilizer, filler, excipient and adjuvant. The product contains non-reducing saccharides in a relatively-high content, so it can be also used as an intermediate for preparing trehalose.

EXAMPLE 9 Conversion of maltopentaose by recombinant enzyme

A high-purity maltopentaose produced by Hayashibara Biochemical Laboratories, Inc., Okayama, Japan, was dissolved in water to give a concentration of 20 w/w %, d.s.b., and the solution was adjusted to pH 6.5, admixed with one unit/g maltopentaose, d.s.b., of a recombinant enzyme obtained by the method in Example 5, and enzymatically reacted at 45° C. for 48 hours. The reaction mixture was heated at 95° C. for 10 min to inactivate the remaining enzyme, cooled, filtered, concentrated and analyzed by the method in Experiment 2-1 to find that about 92 w/w %, d.s.b., of the material maltopentaose was converted into α-maltotriosyl trehalose.

Four jacketed-stainless steel columns, having a diameter of 5.4 cm and a length of 5 m each, were packed to homogeneity with "XT-1016 (Na⁺ -form)", a strong-acid cation exchange resin commercialized by Tokyo Organic Chemical Industries, Ltd., Tokyo, Japan, and cascaded in series to give a total column length of 20 m. The reaction mixture obtained in the above was fed to the columns at a rate of about 5 v/v % against the resin at an inner column temperature of 55° C., and the columns were fed with 55° C. hot water at an SV (space velocity ) of 0.13 to elute saccharide components. Based on the saccharide composition analysis of the eluate, fractions rich in non-reducing saccharides were collected, pooled, concentrated, dried in vacuo and pulverized to obtain a solid product in a yield of about 55%, d.s.b.

Analysis of the solid product by the method in Experiment 2-1 revealed that it had a DE less than about 0.2 and contained 99.0 w/w % α-maltotriosyl trehalose, d.s.b. The product, having a relatively-low hygroscopicity, a significantly-low reducibility as well as a slight sweetness, can be satisfactorily used in food products, cosmetics and pharmaceuticals as a sweetener, taste-improving agent, quality-improving agent, stabilizer, filler, excipient and adjuvant. The product contains non-reducing saccharides in a relatively-high content, so it can be also used as an intermediate for preparing trehalose.

EXAMPLE 10 Conversion of starch hydrolysate by recombinant enzyme

"PINE-DEX #4", a starch hydrolysate produced by Matsutani Chemical Ind., Co., Ltd., Kyoto, Japan, was dissolved in water to give a concentration of 40 w/w %, d.s.b., and the solution was heated to 45° C., adjusted to pH 6.5, admixed with one unit/g starch hydrolysate, d.s.b., of a recombinant enzyme obtained by the method in Example 5, and enzymatically reacted for 96 hours to obtain a reaction mixture containing non-reducing saccharides having trehalose structure as an end unit. Thereafter, the reaction mixture was heated at 100° C. for 10 min to inactivate the remaining enzyme, concentrated up to a 20 w/w % solution, d.s.b., cooled to 55° C., adjusted to pH 4.5, admixed with 10 units/g saccharide, d.s.b., of "GLUCOZYME", a glucoamylase specimen commercialized by Nagase Biochemicals, Ltd., Kyoto, Japan, and enzymatically reacted for 40 hours. The reaction mixture was heated at 100° C. for 10 min to inactivate the remaining enzyme, cooled, decolored in usual manner with an activated charcoal, desalted and purified with an ion exchanger, and concentrated to obtain an about 60 w/w % syrupy product containing about 29.7 w/w % trehalose, d.s.b.

Similarly as in Example 9 except for using "CG6000 (Na⁺ -form), the syrupy product was fractionated, followed by collecting fractions containing about 90 w/w % trehalose, d.s.b. The fractions were pooled, concentrated into an about 75 w/w % solution which was then transferred to a crystallizer, admixed with about 2 w/w % trehalose hydrate as a seed crystal against saccharides, d.s.b., and crystallized under gentle stirring conditions to obtain a massecuite with a crystallinity of about 45%. The massecuite was sprayed downward from a nozzle, equipped at the upper part of a spraying tower at a pressure of about 150 kg/cm² while about 85° C. hot air was flowing downward from the upper part of the tower to accumulate a crystalline powder on a belt conveyer provided on the basement of the tower, followed by gradually transferring it out of the tower. Thereafter, the powder was transferred to an aging tower and aged for 10 hours to complete the crystallization and drying while an about 40° C. hot air was blowing to the contents.

The product, having a substantial non-hygroscopicity and a mild and high-quality sweetness, can be satisfactorily used in food products, cosmetics, pharmaceuticals and feeds as a sweetener, taste-improving agent, quality-improving agent, stabilizer, filler, excipient and adjuvant.

EXAMPLE 11 Conversion of starch hydrolysate by recombinant enzyme

Tapioca starch was suspended in water to give a concentration of 34 w/w e and admixed with 0.1 w/w % calcium carbonate. To the suspension was added 0.2 w/w % per g starch, d.s.b., of "TERMAMYL 60L", an α-amylase specimen commercialized by Novo Nordisk Bioindustri A/S, Copenhagen, Denmark, and enzymatically reacted at 95° C. for 15 min to liquefy the starch. The liquefied product was autoclaved at 120° C. for 10 min to inactivate the remaining enzyme, rapidly cooled to 55° C., adjusted to pH 5.2, admixed with 10 units/g starch, d.s.b., of "α-amylase 2A", an α-amylase specimen commercialized by Ueda Chemical Co., Ltd., Osaka, Japan, and 500 units of an isoamylase specimen commercialized by Hayashibara Biochemical Laboratories, Inc., Okayama, Japan, and enzymatically reacted at 55° C. for 20 hours to form a mixture with a DE of about 29, containing about 60 w/w %, d.s.b., of reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher such as maltotriose, maltotetraose, maltopentaose and maltohexaose. The mixture was autoclaved at 120° C. for 10 min to inactivate the remaining enzyme, rapidly cooled to 45° C., adjusted to pH 6.5, admixed with 2 units/g amrylaceous saccharide, d.s.b., of a recombinant enzyme obtained by the method in Example 6, and enzymatically reacted at 45° C. for 64 hours. The reaction mixture thus obtained was heated at 95° C. for 10 min to inactivate the remaining enzyme, cooled, filtered, decolored in usual manner with an activated charcoal, desalted and purified with an ion exchanger, and concentrated to obtain a syrupy product with a concentration of about 70 w/w %, d.s.b., in a yield of about 90% against the material starch, d.s.b.

Analysis of the syrupy product by the method in Experiment 2-1 revealed that it had a DE of 15.8 and contained as a main component 5.8 w/w % α-glucosyl trehalose, 8.5 w/w % α-maltosyl trehalose, 13.1 w/w % α-maltotriosyl trehalose, 18.9 w/w % α-maltotetraosyl trehalose and 3.6 w/w % α-maltopentaosyl trehalose, d.s.b., and that most of the reducing amylaceous saccharides contained therein were converted into their corresponding non-reducing saccharides. The product, having a mild and moderate sweetness as well as an adequate viscosity and moisture-retaining ability, can be satisfactorily used in food products, cosmetics and pharmaceuticals as a sweetener, taste-improving agent, quality-improving agent, stabilizer, filler, excipient and adjuvant. The product contains non-reducing saccharides in a relatively-high content, so it can be also used as an intermediate for preparing trehalose.

EXAMPLE 12 Conversion of starch hydrolysate by recombinant enzyme

Similarly as in Example 8, a liquefied potato starch was successively subjected to the action of maltotetraose-forming amylase and α-amylase to form a mixture containing about 50 w/w %, d.s.b, of reducing amylaceous saccharides having a degree of glucose polymerization of 3 or higher such as maltotriose, maltotetraose and maltopentaose. The reaction mixture was autoclaved at 120° C. for 10 min to inactivate the remaining enzyme, rapidly cooled to 45° C., adjusted to pH 6.5, admixed with 2 units/g amylaceous saccharide, d.s.b., of a recombinant enzyme obtained by the method in Example 6, and enzymatically reacted at 45° C. for 64 hours. The reaction mixture thus obtained was heated at 95° C. for 10 min to inactivate the remaining enzyme, cooled and filtered, and the filtrate was decolored in usual manner with an activated charcoal, desalted and purified with an ion exchanger, and concentrated to obtain an about 70 w/w % syrupy product in a yield of about 90 w/w % against the material starch, d.s.b.

Analysis of the syrupy product by the method in Experiment 2-1 revealed that it had a DE of 10.3 and contained as a main component 3.6 w/w % α-glucosyl trehalose, 44.0 w/w % α-maltosyl trehalose and 1.0 w/w % α-maltotriosyl trehalose, d.s.b., and that most of the reducing amylaceous saccharides contained in the syrupy product were converted into their corresponding non-reducing saccharides. The product, having a mild and moderate sweetness as well as an adequate viscosity and moisture-retaining ability, can be satisfactorily used in food products, cosmetics and pharmaceuticals as a sweetener, taste-improving agent, quality-improving agent, stabilizer, filler, excipient and adjuvant. The product contains non-reducing saccharides in a relatively-high content, so it can be also used as an intermediate for preparing trehalose.

As is described above, the present invention is based on the finding of a novel enzyme which forms non-reducing saccharides having a trehalose structure as an end unit from reducing saccharides having a degree of glucose polymerization of 3 or higher. The present invention is to explore a way to produce such enzyme by recombinant DNA technology in a relatively-large scale and in a considerably-high yield. The conversion method using the present recombinant enzyme effectively converts reducing amylaceous saccharides into their corresponding non-reducing saccharides which have a mild and high-quality sweetness and an adequate viscosity and moisture-retaining ability, do not have a reducing residue within the molecules, and can sweeten food products without fear of causing an unsatisfactory coloration and deterioration. In addition, the present recombinant enzyme has its amino acid sequence, completely determined and because of this, it can be used for the preparation of trehalose and non-reducing saccharides having trehalose structure as an end unit which are premised on being used in food products without fear of causing side effects.

Thus, the present invention is a significant invention which exerts the aforesaid outstanding action and effect as well as giving a great contribution to the field.

While there has been described what is at present considered to be the preferred embodiments of the invention, it will be understood the various modifications may be made therein, and it is intended to cover in the appended claims all such modifications as fall within the true spirits and scope of the invention.

    __________________________________________________________________________     SEQUENCE LISTING     (1) GENERAL INFORMATION:     (iii) NUMBER OF SEQUENCES: 17     (2) INFORMATION FOR SEQ ID NO:1:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 2316 base pairs     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: cDNA     (ix) FEATURE:     (A) NAME/KEY: CDS     (B) LOCATION: 1..2316     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:     ATGAGGACACCCGCCTCGACCTACCGGCTGCAGATCAGGCGGGGTTTC48     MetArgThrProAlaSerThrTyrArgLeuGlnIleArgArgGlyPhe     151015     ACGCTGTTTGATGCCGCCGAGACCGTGCCCTACCTGAAGTCACTCGGG96     ThrLeuPheAspAlaAlaGluThrValProTyrLeuLysSerLeuGly     202530     GTGGACTGGATCTACCTGTCGCCCATCCTGAAGGCAGAGAGCGGCTCC144     ValAspTrpIleTyrLeuSerProIleLeuLysAlaGluSerGlySer     354045     GACCACGGCTATGACGTCACCGATCCCGCCGTAGTGGACCCGGAGCGC192     AspHisGlyTyrAspValThrAspProAlaValValAspProGluArg     505560     GGCGGCCCTGAAGGGCTGGCCGCGGTGTCCAAGGCGGCCCGCGGTGCC240     GlyGlyProGluGlyLeuAlaAlaValSerLysAlaAlaArgGlyAla     65707580     GGCATGGGCGTGCTGATCGACATCGTGCCGAACCACGTGGGCGTGGCG288     GlyMetGlyValLeuIleAspIleValProAsnHisValGlyValAla     859095     TCGCCGCCGCAGAACCCGTGGTGGTGGTCGCTGCTCAAGGAAGGGCGC336     SerProProGlnAsnProTrpTrpTrpSerLeuLeuLysGluGlyArg     100105110     GGGTCGCCCTACGCCGTGGCGTTCGACGTCGACTGGGACCTGGCGGGG384     GlySerProTyrAlaValAlaPheAspValAspTrpAspLeuAlaGly     115120125     GGCCGCATCCGGATCCCCGTCCTGGGCAGCGACGACGATCTGGACCAG432     GlyArgIleArgIleProValLeuGlySerAspAspAspLeuAspGln     130135140     CTCGAAATCAAGGACGGCGAGCTGCGGTACTACGACCACCGCTTCCCG480     LeuGluIleLysAspGlyGluLeuArgTyrTyrAspHisArgPhePro     145150155160     CTGGCCGAGGGCAGCTACCGGGACGGCGACTCCCCGCAGGACGTCCAC528     LeuAlaGluGlySerTyrArgAspGlyAspSerProGlnAspValHis     165170175     GGCCGGCAGCACTACGAACTCATCGGCTGGCGGCGCGCCGACAATGAA576     GlyArgGlnHisTyrGluLeuIleGlyTrpArgArgAlaAspAsnGlu     180185190     CTGAACTACCGCCGGTTCTTCGCGGTGAACACGCTCGCCGGCATCCGG624     LeuAsnTyrArgArgPhePheAlaValAsnThrLeuAlaGlyIleArg     195200205     GTGGAGGTGCCGCCGGTCTTCGATGAAGCGCACCAGGAGGTGGTGCGC672     ValGluValProProValPheAspGluAlaHisGlnGluValValArg     210215220     TGGTTCCGTGCGGGGCTCGCCGACGGGCTGCGGATCGACCACCCGGAC720     TrpPheArgAlaGlyLeuAlaAspGlyLeuArgIleAspHisProAsp     225230235240     GGCCTGGCCGATCCCGAGGGGTATTTGAAGCGGCTCCGTGAGGTCACC768     GlyLeuAlaAspProGluGlyTyrLeuLysArgLeuArgGluValThr     245250255     GGGGGCGCGTACCTGCTCATCGAAAAGATCCTCGAGCCGGGCGAACAG816     GlyGlyAlaTyrLeuLeuIleGluLysIleLeuGluProGlyGluGln     260265270     TTGCCGGCCAGCTTCGAGTGCGAAGGCACCACCGGCTACGACGCCCTC864     LeuProAlaSerPheGluCysGluGlyThrThrGlyTyrAspAlaLeu     275280285     GCGGATGTCGACAGGGTCTTCGTGGACCCGCGGGGACAGGTGCCGCTG912     AlaAspValAspArgValPheValAspProArgGlyGlnValProLeu     290295300     GACCGTCTGGACGCACGGCTGCGCGGCGGTGCGCCGGCCGACTACGAG960     AspArgLeuAspAlaArgLeuArgGlyGlyAlaProAlaAspTyrGlu     305310315320     GACATGATCCGCGGGACCAAGCGCCGGATCACCGACGGCATCCTGCAC1008     AspMetIleArgGlyThrLysArgArgIleThrAspGlyIleLeuHis     325330335     TCCGAGATCCTGCGCCTTGCCAGGCTGGTGCCCGAGCAGACCGGAATT1056     SerGluIleLeuArgLeuAlaArgLeuValProGluGlnThrGlyIle     340345350     CCCGGGGAGGCGGCCGCGGATGCGATCGCGGAGATCATCGCGGCCTTC1104     ProGlyGluAlaAlaAlaAspAlaIleAlaGluIleIleAlaAlaPhe     355360365     CCGGTCTACCGGTCCTATCTTCCCGAGGGCGCGGAGATCCTGAAGGAG1152     ProValTyrArgSerTyrLeuProGluGlyAlaGluIleLeuLysGlu     370375380     GCCTGCGACCTCGCCGCGCGGAGGCGTCCGGAACTGGGCCAGACCGTC1200     AlaCysAspLeuAlaAlaArgArgArgProGluLeuGlyGlnThrVal     385390395400     CAGCTGCTGCAGCCGCTGCTGCTGGATACCGACCTCGAGATTTCCCGC1248     GlnLeuLeuGlnProLeuLeuLeuAspThrAspLeuGluIleSerArg     405410415     AGGTTCCAGCAGACCTCGGGAATGGTCATGGCCAAAGGCGTGGAGGAC1296     ArgPheGlnGlnThrSerGlyMetValMetAlaLysGlyValGluAsp     420425430     ACCGCGTTCTTCCGCTACAACCGGCTGGGAACGCTCACCGAGGTGGGC1344     ThrAlaPhePheArgTyrAsnArgLeuGlyThrLeuThrGluValGly     435440445     GCCGACCCCACCGAGTTCTCGCTGGAACCGGAGGAGTTTCACGTCCGG1392     AlaAspProThrGluPheSerLeuGluProGluGluPheHisValArg     450455460     ATGGCCCGCCGGCAGGCCGAACTCCCGCTCTCCATGACCACCCTGAGC1440     MetAlaArgArgGlnAlaGluLeuProLeuSerMetThrThrLeuSer     465470475480     ACGCACGACACCAAGCGCAGCGAGGACACCCGGGCCCGGATCTCGGTG1488     ThrHisAspThrLysArgSerGluAspThrArgAlaArgIleSerVal     485490495     ATCGCCGAGGTCGCGCCTGAATGGGAAAAGGCCCTGGACAGGCTGAAC1536     IleAlaGluValAlaProGluTrpGluLysAlaLeuAspArgLeuAsn     500505510     ACCCTCGCTCCGCTGCCGGACGGCCCGCTCTCCACGCTGCTCTGGCAG1584     ThrLeuAlaProLeuProAspGlyProLeuSerThrLeuLeuTrpGln     515520525     GCGATTGCGGGGGCATGGCCGGCCAGCCGGGAACGCCTTCAGTCCTAC1632     AlaIleAlaGlyAlaTrpProAlaSerArgGluArgLeuGlnSerTyr     530535540     GCCCTGAAAGCGGCGCGCGAAGCCGGGAACTCGACCAGCTGGACCGAT1680     AlaLeuLysAlaAlaArgGluAlaGlyAsnSerThrSerTrpThrAsp     545550555560     CCGGACCCGGCATTCGAGGAGGCACTTTCCGCCGTCGTCGACTCCGCC1728     ProAspProAlaPheGluGluAlaLeuSerAlaValValAspSerAla     565570575     TTCGACAATCCGGAGGTGCGTGCGGAACTTGAGGCCCTGGTGGGCCTC1776     PheAspAsnProGluValArgAlaGluLeuGluAlaLeuValGlyLeu     580585590     CTTGCGCCGCACGGTGCGTCCAACTCGCTCGCGGCAAAGCTTGTCCAG1824     LeuAlaProHisGlyAlaSerAsnSerLeuAlaAlaLysLeuValGln     595600605     CTGACCATGCCGGGCGTTCCGGACGTGTACCAGGGCACCGAGTTCTGG1872     LeuThrMetProGlyValProAspValTyrGlnGlyThrGluPheTrp     610615620     GACAGGTCGCTGACCGATCCGGACAACCGGCGCCCCTTCAGCTTCGCC1920     AspArgSerLeuThrAspProAspAsnArgArgProPheSerPheAla     625630635640     GAACGGATTAGGGCCTTGGACCAGTTGGACGCCGGCCACCGTCCGGAC1968     GluArgIleArgAlaLeuAspGlnLeuAspAlaGlyHisArgProAsp     645650655     TCCTTCCAGGACGAGGCGGTCAAGCTGCTGGTCACCTCGAGGGCGCTG2016     SerPheGlnAspGluAlaValLysLeuLeuValThrSerArgAlaLeu     660665670     CGGCTGCGGCGGAACCGGCCCGAGCTCTTCACCGGCTACCGCCCCGTG2064     ArgLeuArgArgAsnArgProGluLeuPheThrGlyTyrArgProVal     675680685     CATGCCAGGGGCCCCGCCGCCGGGCACCTGGTGGCGTTCGACCGCGGC2112     HisAlaArgGlyProAlaAlaGlyHisLeuValAlaPheAspArgGly     690695700     GCCGGGGGAGTGCTGGCGCTTGCCACCCGGCTCCCCTACGGGCTGGAA2160     AlaGlyGlyValLeuAlaLeuAlaThrArgLeuProTyrGlyLeuGlu     705710715720     CAGTCGGGCGGCTGGCGGGACACCGCCGTCGAGCTTGAAGCCGCCATG2208     GlnSerGlyGlyTrpArgAspThrAlaValGluLeuGluAlaAlaMet     725730735     ACGGACGAACTGACCGGCTCCACTTTCGGGCCGGGACCGGCGGCGCTG2256     ThrAspGluLeuThrGlySerThrPheGlyProGlyProAlaAlaLeu     740745750     TCAGAAGTCTTCCGGGCCTACCCGGTGGCCTTGTTGGTCCCCGCGACA2304     SerGluValPheArgAlaTyrProValAlaLeuLeuValProAlaThr     755760765     GGAGGCAAGTCA2316     GlyGlyLysSer     770     (2) INFORMATION FOR SEQ ID NO:2:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 772 amino acids     (B) TYPE: amino acid     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: protein     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:     MetArgThrProAlaSerThrTyrArgLeuGlnIleArgArgGlyPhe     151015     ThrLeuPheAspAlaAlaGluThrValProTyrLeuLysSerLeuGly     202530     ValAspTrpIleTyrLeuSerProIleLeuLysAlaGluSerGlySer     354045     AspHisGlyTyrAspValThrAspProAlaValValAspProGluArg     505560     GlyGlyProGluGlyLeuAlaAlaValSerLysAlaAlaArgGlyAla     65707580     GlyMetGlyValLeuIleAspIleValProAsnHisValGlyValAla     859095     SerProProGlnAsnProTrpTrpTrpSerLeuLeuLysGluGlyArg     100105110     GlySerProTyrAlaValAlaPheAspValAspTrpAspLeuAlaGly     115120125     GlyArgIleArgIleProValLeuGlySerAspAspAspLeuAspGln     130135140     LeuGluIleLysAspGlyGluLeuArgTyrTyrAspHisArgPhePro     145150155160     LeuAlaGluGlySerTyrArgAspGlyAspSerProGlnAspValHis     165170175     GlyArgGlnHisTyrGluLeuIleGlyTrpArgArgAlaAspAsnGlu     180185190     LeuAsnTyrArgArgPhePheAlaValAsnThrLeuAlaGlyIleArg     195200205     ValGluValProProValPheAspGluAlaHisGlnGluValValArg     210215220     TrpPheArgAlaGlyLeuAlaAspGlyLeuArgIleAspHisProAsp     225230235240     GlyLeuAlaAspProGluGlyTyrLeuLysArgLeuArgGluValThr     245250255     GlyGlyAlaTyrLeuLeuIleGluLysIleLeuGluProGlyGluGln     260265270     LeuProAlaSerPheGluCysGluGlyThrThrGlyTyrAspAlaLeu     275280285     AlaAspValAspArgValPheValAspProArgGlyGlnValProLeu     290295300     AspArgLeuAspAlaArgLeuArgGlyGlyAlaProAlaAspTyrGlu     305310315320     AspMetIleArgGlyThrLysArgArgIleThrAspGlyIleLeuHis     325330335     SerGluIleLeuArgLeuAlaArgLeuValProGluGlnThrGlyIle     340345350     ProGlyGluAlaAlaAlaAspAlaIleAlaGluIleIleAlaAlaPhe     355360365     ProValTyrArgSerTyrLeuProGluGlyAlaGluIleLeuLysGlu     370375380     AlaCysAspLeuAlaAlaArgArgArgProGluLeuGlyGlnThrVal     385390395400     GlnLeuLeuGlnProLeuLeuLeuAspThrAspLeuGluIleSerArg     405410415     ArgPheGlnGlnThrSerGlyMetValMetAlaLysGlyValGluAsp     420425430     ThrAlaPhePheArgTyrAsnArgLeuGlyThrLeuThrGluValGly     435440445     AlaAspProThrGluPheSerLeuGluProGluGluPheHisValArg     450455460     MetAlaArgArgGlnAlaGluLeuProLeuSerMetThrThrLeuSer     465470475480     ThrHisAspThrLysArgSerGluAspThrArgAlaArgIleSerVal     485490495     IleAlaGluValAlaProGluTrpGluLysAlaLeuAspArgLeuAsn     500505510     ThrLeuAlaProLeuProAspGlyProLeuSerThrLeuLeuTrpGln     515520525     AlaIleAlaGlyAlaTrpProAlaSerArgGluArgLeuGlnSerTyr     530535540     AlaLeuLysAlaAlaArgGluAlaGlyAsnSerThrSerTrpThrAsp     545550555560     ProAspProAlaPheGluGluAlaLeuSerAlaValValAspSerAla     565570575     PheAspAsnProGluValArgAlaGluLeuGluAlaLeuValGlyLeu     580585590     LeuAlaProHisGlyAlaSerAsnSerLeuAlaAlaLysLeuValGln     595600605     LeuThrMetProGlyValProAspValTyrGlnGlyThrGluPheTrp     610615620     AspArgSerLeuThrAspProAspAsnArgArgProPheSerPheAla     625630635640     GluArgIleArgAlaLeuAspGlnLeuAspAlaGlyHisArgProAsp     645650655     SerPheGlnAspGluAlaValLysLeuLeuValThrSerArgAlaLeu     660665670     ArgLeuArgArgAsnArgProGluLeuPheThrGlyTyrArgProVal     675680685     HisAlaArgGlyProAlaAlaGlyHisLeuValAlaPheAspArgGly     690695700     AlaGlyGlyValLeuAlaLeuAlaThrArgLeuProTyrGlyLeuGlu     705710715720     GlnSerGlyGlyTrpArgAspThrAlaValGluLeuGluAlaAlaMet     725730735     ThrAspGluLeuThrGlySerThrPheGlyProGlyProAlaAlaLeu     740745750     SerGluValPheArgAlaTyrProValAlaLeuLeuValProAlaThr     755760765     GlyGlyLysSer     770     (2) INFORMATION FOR SEQ ID NO:3:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 2325 base pairs     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: cDNA     (ix) FEATURE:     (A) NAME/KEY: CDS     (B) LOCATION: 1..2325     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:     ATGAGAACGCCAGTCTCCACGTACAGGCTGCAGATCAGGAAGGGATTC48     MetArgThrProValSerThrTyrArgLeuGlnIleArgLysGlyPhe     775780785     ACACTCTTCGACGCGGCCAAAACCGTTCCGTACCTGCACTCGCTCGGC96     ThrLeuPheAspAlaAlaLysThrValProTyrLeuHisSerLeuGly     790795800     GTCGACTGGGTCTACCTTTCTCCGGTCCTGACTGCCGAGCAGGGCTCC144     ValAspTrpValTyrLeuSerProValLeuThrAlaGluGlnGlySer     805810815820     GACCACGGGTACGACGTCACCGATCCCTCCGCCGTCGACCCCGAACGC192     AspHisGlyTyrAspValThrAspProSerAlaValAspProGluArg     825830835     GGCGGGCCGGAGGGCCTCGCGGCGGTTTCCAAGGCGGCCCGCGCCGCG240     GlyGlyProGluGlyLeuAlaAlaValSerLysAlaAlaArgAlaAla     840845850     GGCATGGGCGTGCTGATCGACATCGTGCCCAACCACGTGGGCGTCGCG288     GlyMetGlyValLeuIleAspIleValProAsnHisValGlyValAla     855860865     ACGCCGGCGCAGAACCCCTGGTGGTGGTCGCTGCTCAAGGAGGGACGC336     ThrProAlaGlnAsnProTrpTrpTrpSerLeuLeuLysGluGlyArg     870875880     CAGTCCCGTTACGCGGAGGCGTTCGACGTCGATTGGGACCTCGCCGGG384     GlnSerArgTyrAlaGluAlaPheAspValAspTrpAspLeuAlaGly     885890895900     GGACGCATCCGGCTGCCGGTGCTCGGCAGCGACGATGACCTCGACCAG432     GlyArgIleArgLeuProValLeuGlySerAspAspAspLeuAspGln     905910915     CTCGAAATCAGGGACGGGGAGCTGCGGTACTACGACCACCGATTCCCG480     LeuGluIleArgAspGlyGluLeuArgTyrTyrAspHisArgPhePro     920925930     CTCGCCGAGGGAACCTACGCCGAAGGCGACGCCCCGCGGGATGTCCAC528     LeuAlaGluGlyThrTyrAlaGluGlyAspAlaProArgAspValHis     935940945     GCCCGGCAGCACTACGAGCTCATCGGCTGGCGCCGCGCGGACAACGAG576     AlaArgGlnHisTyrGluLeuIleGlyTrpArgArgAlaAspAsnGlu     950955960     CTGAACTACCGCCGCTTTTTCGCGGTGAACACGCTCGCCGGCGTCCGC624     LeuAsnTyrArgArgPhePheAlaValAsnThrLeuAlaGlyValArg     965970975980     GTGGAAATCCCCGCCGTCTTCGACGAGGCACACCAGGAGGTGGTGCGC672     ValGluIleProAlaValPheAspGluAlaHisGlnGluValValArg     985990995     TGGTTCCGCGAGGACCTTGCGGACGGCCTGCGGATCGACCACCCGGAC720     TrpPheArgGluAspLeuAlaAspGlyLeuArgIleAspHisProAsp     100010051010     GGCCTCGCTGACCCCGAGGGGTACCTGAAGCGACTCCGGGAAGTCACC768     GlyLeuAlaAspProGluGlyTyrLeuLysArgLeuArgGluValThr     101510201025     GGCGGCGCTTACCTGCTGATCGAAAAGATCCTGGAGCCGGGGGAGCAG816     GlyGlyAlaTyrLeuLeuIleGluLysIleLeuGluProGlyGluGln     103010351040     CTGCCCGCCAGCTTCGAGTGTGAAGGCACCACAGGCTACGACGCCCTC864     LeuProAlaSerPheGluCysGluGlyThrThrGlyTyrAspAlaLeu     1045105010551060     GCCGACGTCGACCGGGTTCTCGTGGACCCGCGCGGCCAGGAACCGCTG912     AlaAspValAspArgValLeuValAspProArgGlyGlnGluProLeu     106510701075     GACCGGCTTGACGCGTCCCTGCGTGGCGGCGAGCCCGCCGACTACCAG960     AspArgLeuAspAlaSerLeuArgGlyGlyGluProAlaAspTyrGln     108010851090     GACATGATCCGCGGAACCAAGCGCCGGATCACCGACGGTATCCTGCAC1008     AspMetIleArgGlyThrLysArgArgIleThrAspGlyIleLeuHis     109511001105     TCGGAGATCCTGCGGCTGGCCCGGCTGGTTCCGGGCGACGCCAACGTT1056     SerGluIleLeuArgLeuAlaArgLeuValProGlyAspAlaAsnVal     111011151120     TCAATCGACGCCGGAGCCGACGCTCTCGCCGAAATCATCGCCGCCTTC1104     SerIleAspAlaGlyAlaAspAlaLeuAlaGluIleIleAlaAlaPhe     1125113011351140     CCGGTCTACCGCACCTACCTGCCGGAGGGCGCCGAGGTCCTGAAGGAG1152     ProValTyrArgThrTyrLeuProGluGlyAlaGluValLeuLysGlu     114511501155     GCGTGCGAGCTTGCCGCGCGTAGGCGGCCGGAACTCGACCAGGCCATC1200     AlaCysGluLeuAlaAlaArgArgArgProGluLeuAspGlnAlaIle     116011651170     CAGGCTCTGCAGCCGCTGCTGCTGGACACGGACCTCGAGCTTGCCCGG1248     GlnAlaLeuGlnProLeuLeuLeuAspThrAspLeuGluLeuAlaArg     117511801185     CGCTTCCAGCAGACCTCGGGCATGGTCATGGCCAAGGGCGTGGAGGAC1296     ArgPheGlnGlnThrSerGlyMetValMetAlaLysGlyValGluAsp     119011951200     ACCGCGTTCTTCCGCTACAACCGCCTGGGCACCCTCACGGAAGTGGGC1344     ThrAlaPhePheArgTyrAsnArgLeuGlyThrLeuThrGluValGly     1205121012151220     GCCGACCCCACCGAGTTCGCCGTGGAGCCGGACGAGTTCCACGCCCGG1392     AlaAspProThrGluPheAlaValGluProAspGluPheHisAlaArg     122512301235     CTGGCACGCCGGCAGGCCGAGCTTCCGCTGTCCATGACGACGCTGAGC1440     LeuAlaArgArgGlnAlaGluLeuProLeuSerMetThrThrLeuSer     124012451250     ACGCACGACACCAAGCGCAGCGAGGACACCCGAGCAAGGATTTCGGTC1488     ThrHisAspThrLysArgSerGluAspThrArgAlaArgIleSerVal     125512601265     ATTTCCGAGGTTGCGGGTGACTGGGAAAAGGCCTTGAACCGGCTGCGC1536     IleSerGluValAlaGlyAspTrpGluLysAlaLeuAsnArgLeuArg     127012751280     GACCTGGCCCCGCTGCCGGACGGCCCGCTGTCCGCGCTGCTCTGGCAG1584     AspLeuAlaProLeuProAspGlyProLeuSerAlaLeuLeuTrpGln     1285129012951300     GCCATTGCCGGCGCCTGGCCCGCCAGCCGGGAACGCCTGCAGTACTAC1632     AlaIleAlaGlyAlaTrpProAlaSerArgGluArgLeuGlnTyrTyr     130513101315     GCGCTGAAGGCCGCGCGTGAAGCGGGGAACTCGACCAACTGGACCGAT1680     AlaLeuLysAlaAlaArgGluAlaGlyAsnSerThrAsnTrpThrAsp     132013251330     CCGGCCCCCGCGTTCGAGGAGAAGCTGAAGGCCGCGGTCGACGCCGTG1728     ProAlaProAlaPheGluGluLysLeuLysAlaAlaValAspAlaVal     133513401345     TTCGACAATCCCGCCGTGCAGGCCGAGGTGGAAGCCCTCGTCGAGCTC1776     PheAspAsnProAlaValGlnAlaGluValGluAlaLeuValGluLeu     135013551360     CTGGAGCCGTACGGAGCTTCGAACTCCCTCGCCGCCAAGCTCGTGCAG1824     LeuGluProTyrGlyAlaSerAsnSerLeuAlaAlaLysLeuValGln     1365137013751380     CTGACCATGCCCGGCGTCCCGGACGTCTACCAGGGCACGGAGTTCTGG1872     LeuThrMetProGlyValProAspValTyrGlnGlyThrGluPheTrp     138513901395     GACCGGTCGCTGACGGACCCGGACAACCGGCGGCCGTTCAGCTTCGAC1920     AspArgSerLeuThrAspProAspAsnArgArgProPheSerPheAsp     140014051410     GACCGCCGCGCCGCGCTGGAGCAGCTGGATGCCGGCGACCTTCCCGCG1968     AspArgArgAlaAlaLeuGluGlnLeuAspAlaGlyAspLeuProAla     141514201425     TCATTTACCGATGAGCGGACGAAGCTGCTAGTGACGTCGCGCGCGCTG2016     SerPheThrAspGluArgThrLysLeuLeuValThrSerArgAlaLeu     143014351440     CGGCTGCGCCGGGACCGTCCGGAGCTGTTCACGGGGTACCGGCCGGTC2064     ArgLeuArgArgAspArgProGluLeuPheThrGlyTyrArgProVal     1445145014551460     CTGGCCAGCGGGCCCGCCGCCGGGCACCTGCTCGCGTTCGACCGCGGC2112     LeuAlaSerGlyProAlaAlaGlyHisLeuLeuAlaPheAspArgGly     146514701475     ACCGCGGCGGCGCCGGGTGCATTGACCCTCGCCACGCGGCTTCCCTAC2160     ThrAlaAlaAlaProGlyAlaLeuThrLeuAlaThrArgLeuProTyr     148014851490     GGGCTGGAACAGTCGGGTGGATGGCGGGACACCGCCGTCGAACTTAAC2208     GlyLeuGluGlnSerGlyGlyTrpArgAspThrAlaValGluLeuAsn     149515001505     ACCGCCATGAAAGACGAACTGACCGGTGCCGGCTTCGGACCGGGGGCA2256     ThrAlaMetLysAspGluLeuThrGlyAlaGlyPheGlyProGlyAla     151015151520     GTGAAGATCGCCGACATCTTCCGGTCGTTCCCCGTTGCGCTGCTGGTG2304     ValLysIleAlaAspIlePheArgSerPheProValAlaLeuLeuVal     1525153015351540     CCGCAGACAGGAGGAGAGTCA2325     ProGlnThrGlyGlyGluSer     1545     (2) INFORMATION FOR SEQ ID NO:4:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 775 amino acids     (B) TYPE: amino acid     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: protein     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:     MetArgThrProValSerThrTyrArgLeuGlnIleArgLysGlyPhe     151015     ThrLeuPheAspAlaAlaLysThrValProTyrLeuHisSerLeuGly     202530     ValAspTrpValTyrLeuSerProValLeuThrAlaGluGlnGlySer     354045     AspHisGlyTyrAspValThrAspProSerAlaValAspProGluArg     505560     GlyGlyProGluGlyLeuAlaAlaValSerLysAlaAlaArgAlaAla     65707580     GlyMetGlyValLeuIleAspIleValProAsnHisValGlyValAla     859095     ThrProAlaGlnAsnProTrpTrpTrpSerLeuLeuLysGluGlyArg     100105110     GlnSerArgTyrAlaGluAlaPheAspValAspTrpAspLeuAlaGly     115120125     GlyArgIleArgLeuProValLeuGlySerAspAspAspLeuAspGln     130135140     LeuGluIleArgAspGlyGluLeuArgTyrTyrAspHisArgPhePro     145150155160     LeuAlaGluGlyThrTyrAlaGluGlyAspAlaProArgAspValHis     165170175     AlaArgGlnHisTyrGluLeuIleGlyTrpArgArgAlaAspAsnGlu     180185190     LeuAsnTyrArgArgPhePheAlaValAsnThrLeuAlaGlyValArg     195200205     ValGluIleProAlaValPheAspGluAlaHisGlnGluValValArg     210215220     TrpPheArgGluAspLeuAlaAspGlyLeuArgIleAspHisProAsp     225230235240     GlyLeuAlaAspProGluGlyTyrLeuLysArgLeuArgGluValThr     245250255     GlyGlyAlaTyrLeuLeuIleGluLysIleLeuGluProGlyGluGln     260265270     LeuProAlaSerPheGluCysGluGlyThrThrGlyTyrAspAlaLeu     275280285     AlaAspValAspArgValLeuValAspProArgGlyGlnGluProLeu     290295300     AspArgLeuAspAlaSerLeuArgGlyGlyGluProAlaAspTyrGln     305310315320     AspMetIleArgGlyThrLysArgArgIleThrAspGlyIleLeuHis     325330335     SerGluIleLeuArgLeuAlaArgLeuValProGlyAspAlaAsnVal     340345350     SerIleAspAlaGlyAlaAspAlaLeuAlaGluIleIleAlaAlaPhe     355360365     ProValTyrArgThrTyrLeuProGluGlyAlaGluValLeuLysGlu     370375380     AlaCysGluLeuAlaAlaArgArgArgProGluLeuAspGlnAlaIle     385390395400     GlnAlaLeuGlnProLeuLeuLeuAspThrAspLeuGluLeuAlaArg     405410415     ArgPheGlnGlnThrSerGlyMetValMetAlaLysGlyValGluAsp     420425430     ThrAlaPhePheArgTyrAsnArgLeuGlyThrLeuThrGluValGly     435440445     AlaAspProThrGluPheAlaValGluProAspGluPheHisAlaArg     450455460     LeuAlaArgArgGlnAlaGluLeuProLeuSerMetThrThrLeuSer     465470475480     ThrHisAspThrLysArgSerGluAspThrArgAlaArgIleSerVal     485490495     IleSerGluValAlaGlyAspTrpGluLysAlaLeuAsnArgLeuArg     500505510     AspLeuAlaProLeuProAspGlyProLeuSerAlaLeuLeuTrpGln     515520525     AlaIleAlaGlyAlaTrpProAlaSerArgGluArgLeuGlnTyrTyr     530535540     AlaLeuLysAlaAlaArgGluAlaGlyAsnSerThrAsnTrpThrAsp     545550555560     ProAlaProAlaPheGluGluLysLeuLysAlaAlaValAspAlaVal     565570575     PheAspAsnProAlaValGlnAlaGluValGluAlaLeuValGluLeu     580585590     LeuGluProTyrGlyAlaSerAsnSerLeuAlaAlaLysLeuValGln     595600605     LeuThrMetProGlyValProAspValTyrGlnGlyThrGluPheTrp     610615620     AspArgSerLeuThrAspProAspAsnArgArgProPheSerPheAsp     625630635640     AspArgArgAlaAlaLeuGluGlnLeuAspAlaGlyAspLeuProAla     645650655     SerPheThrAspGluArgThrLysLeuLeuValThrSerArgAlaLeu     660665670     ArgLeuArgArgAspArgProGluLeuPheThrGlyTyrArgProVal     675680685     LeuAlaSerGlyProAlaAlaGlyHisLeuLeuAlaPheAspArgGly     690695700     ThrAlaAlaAlaProGlyAlaLeuThrLeuAlaThrArgLeuProTyr     705710715720     GlyLeuGluGlnSerGlyGlyTrpArgAspThrAlaValGluLeuAsn     725730735     ThrAlaMetLysAspGluLeuThrGlyAlaGlyPheGlyProGlyAla     740745750     ValLysIleAlaAspIlePheArgSerPheProValAlaLeuLeuVal     755760765     ProGlnThrGlyGlyGluSer     770775     (2) INFORMATION FOR SEQ ID NO:5:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 14 base pairs     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: cDNA     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:     CCNGARTGGGARAA14     (2) INFORMATION FOR SEQ ID NO:6:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 14 base pairs     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: cDNA     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:     ACNGARTTYTGGGA14     (2) INFORMATION FOR SEQ ID NO:7:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 17 base pairs     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: cDNA     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:     GTAAAACGACGGCCAGT17     (2) INFORMATION FOR SEQ ID NO:8:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 17 base pairs     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: cDNA     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:     TTYGAYGTNGAYTGGGA17     (2) INFORMATION FOR SEQ ID NO:9:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 14 base pairs     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: cDNA     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:     ACNGARTTYTGGGA14     (2) INFORMATION FOR SEQ ID NO:10:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 2936 base pairs     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: cDNA     (ix) FEATURE:     (A) NAME/KEY: CDS     (B) LOCATION: 565..2880     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:     CGTGCTCTACTTCAACGCGCACGACGGCGACGTCGTGTTCAAGCTCCCGTCGGATGAATA60     CGCCCCGGCCTGGGACGTCATCATCGACACCGCCGGCGCGGGTGCCGATTCCGAACCCGT120     GCAGGCTGGCGGCAAACTCACCGTGGCAGCGAAATCGCTCGTGGTGCTCCGTGCCCACAG180     CGCCCCGGAGGAGGAACCGGACCACTCGGTGGCCGCCTCCCTCGCAGCGCTGACGCAGAC240     TGCGACCGCCGAAACCGCGGCGCTCACCGCCCCCACCGTTCCGGAGCCGAGGAAGACCAA300     GAAGGCAGCGCCGAAGCCGGAAGAGGAGGCTCCCGACGAGGCGGCGCCGAAGCCGGAAGA360     GAAGGCTCCCGACGAGGCGGCGGCGAAGCCGGAAGAGGCTGCTTCCGACGAGGCGGCGGC420     GAAGCCGGAAGAGAAGGCTCCCGACGAGGCGGCGGCGAAGCCGGAAGAGGCTGCTTCCGA480     CGAGGCGGCGGCGAAGCCCGCGGGGAAGGCAGCGGCCAAAACGGCCGGCAGGCGAGCGCC540     AGGCAAGCAGGGCGGGACGGGCTCATGAGGACACCCGCCTCGACCTACCGG591     MetArgThrProAlaSerThrTyrArg     780     CTGCAGATCAGGCGGGGTTTCACGCTGTTTGATGCCGCCGAGACCGTG639     LeuGlnIleArgArgGlyPheThrLeuPheAspAlaAlaGluThrVal     785790795800     CCCTACCTGAAGTCACTCGGGGTGGACTGGATCTACCTGTCGCCCATC687     ProTyrLeuLysSerLeuGlyValAspTrpIleTyrLeuSerProIle     805810815     CTGAAGGCAGAGAGCGGCTCCGACCACGGCTATGACGTCACCGATCCC735     LeuLysAlaGluSerGlySerAspHisGlyTyrAspValThrAspPro     820825830     GCCGTAGTGGACCCGGAGCGCGGCGGCCCTGAAGGGCTGGCCGCGGTG783     AlaValValAspProGluArgGlyGlyProGluGlyLeuAlaAlaVal     835840845     TCCAAGGCGGCCCGCGGTGCCGGCATGGGCGTGCTGATCGACATCGTG831     SerLysAlaAlaArgGlyAlaGlyMetGlyValLeuIleAspIleVal     850855860     CCGAACCACGTGGGCGTGGCGTCGCCGCCGCAGAACCCGTGGTGGTGG879     ProAsnHisValGlyValAlaSerProProGlnAsnProTrpTrpTrp     865870875880     TCGCTGCTCAAGGAAGGGCGCGGGTCGCCCTACGCCGTGGCGTTCGAC927     SerLeuLeuLysGluGlyArgGlySerProTyrAlaValAlaPheAsp     885890895     GTCGACTGGGACCTGGCGGGGGGCCGCATCCGGATCCCCGTCCTGGGC975     ValAspTrpAspLeuAlaGlyGlyArgIleArgIleProValLeuGly     900905910     AGCGACGACGATCTGGACCAGCTCGAAATCAAGGACGGCGAGCTGCGG1023     SerAspAspAspLeuAspGlnLeuGluIleLysAspGlyGluLeuArg     915920925     TACTACGACCACCGCTTCCCGCTGGCCGAGGGCAGCTACCGGGACGGC1071     TyrTyrAspHisArgPheProLeuAlaGluGlySerTyrArgAspGly     930935940     GACTCCCCGCAGGACGTCCACGGCCGGCAGCACTACGAACTCATCGGC1119     AspSerProGlnAspValHisGlyArgGlnHisTyrGluLeuIleGly     945950955960     TGGCGGCGCGCCGACAATGAACTGAACTACCGCCGGTTCTTCGCGGTG1167     TrpArgArgAlaAspAsnGluLeuAsnTyrArgArgPhePheAlaVal     965970975     AACACGCTCGCCGGCATCCGGGTGGAGGTGCCGCCGGTCTTCGATGAA1215     AsnThrLeuAlaGlyIleArgValGluValProProValPheAspGlu     980985990     GCGCACCAGGAGGTGGTGCGCTGGTTCCGTGCGGGGCTCGCCGACGGG1263     AlaHisGlnGluValValArgTrpPheArgAlaGlyLeuAlaAspGly     99510001005     CTGCGGATCGACCACCCGGACGGCCTGGCCGATCCCGAGGGGTATTTG1311     LeuArgIleAspHisProAspGlyLeuAlaAspProGluGlyTyrLeu     101010151020     AAGCGGCTCCGTGAGGTCACCGGGGGCGCGTACCTGCTCATCGAAAAG1359     LysArgLeuArgGluValThrGlyGlyAlaTyrLeuLeuIleGluLys     1025103010351040     ATCCTCGAGCCGGGCGAACAGTTGCCGGCCAGCTTCGAGTGCGAAGGC1407     IleLeuGluProGlyGluGlnLeuProAlaSerPheGluCysGluGly     104510501055     ACCACCGGCTACGACGCCCTCGCGGATGTCGACAGGGTCTTCGTGGAC1455     ThrThrGlyTyrAspAlaLeuAlaAspValAspArgValPheValAsp     106010651070     CCGCGGGGACAGGTGCCGCTGGACCGTCTGGACGCACGGCTGCGCGGC1503     ProArgGlyGlnValProLeuAspArgLeuAspAlaArgLeuArgGly     107510801085     GGTGCGCCGGCCGACTACGAGGACATGATCCGCGGGACCAAGCGCCGG1551     GlyAlaProAlaAspTyrGluAspMetIleArgGlyThrLysArgArg     109010951100     ATCACCGACGGCATCCTGCACTCCGAGATCCTGCGCCTTGCCAGGCTG1599     IleThrAspGlyIleLeuHisSerGluIleLeuArgLeuAlaArgLeu     1105111011151120     GTGCCCGAGCAGACCGGAATTCCCGGGGAGGCGGCCGCGGATGCGATC1647     ValProGluGlnThrGlyIleProGlyGluAlaAlaAlaAspAlaIle     112511301135     GCGGAGATCATCGCGGCCTTCCCGGTCTACCGGTCCTATCTTCCCGAG1695     AlaGluIleIleAlaAlaPheProValTyrArgSerTyrLeuProGlu     114011451150     GGCGCGGAGATCCTGAAGGAGGCCTGCGACCTCGCCGCGCGGAGGCGT1743     GlyAlaGluIleLeuLysGluAlaCysAspLeuAlaAlaArgArgArg     115511601165     CCGGAACTGGGCCAGACCGTCCAGCTGCTGCAGCCGCTGCTGCTGGAT1791     ProGluLeuGlyGlnThrValGlnLeuLeuGlnProLeuLeuLeuAsp     117011751180     ACCGACCTCGAGATTTCCCGCAGGTTCCAGCAGACCTCGGGAATGGTC1839     ThrAspLeuGluIleSerArgArgPheGlnGlnThrSerGlyMetVal     1185119011951200     ATGGCCAAAGGCGTGGAGGACACCGCGTTCTTCCGCTACAACCGGCTG1887     MetAlaLysGlyValGluAspThrAlaPhePheArgTyrAsnArgLeu     120512101215     GGAACGCTCACCGAGGTGGGCGCCGACCCCACCGAGTTCTCGCTGGAA1935     GlyThrLeuThrGluValGlyAlaAspProThrGluPheSerLeuGlu     122012251230     CCGGAGGAGTTTCACGTCCGGATGGCCCGCCGGCAGGCCGAACTCCCG1983     ProGluGluPheHisValArgMetAlaArgArgGlnAlaGluLeuPro     123512401245     CTCTCCATGACCACCCTGAGCACGCACGACACCAAGCGCAGCGAGGAC2031     LeuSerMetThrThrLeuSerThrHisAspThrLysArgSerGluAsp     125012551260     ACCCGGGCCCGGATCTCGGTGATCGCCGAGGTCGCGCCTGAATGGGAA2079     ThrArgAlaArgIleSerValIleAlaGluValAlaProGluTrpGlu     1265127012751280     AAGGCCCTGGACAGGCTGAACACCCTCGCTCCGCTGCCGGACGGCCCG2127     LysAlaLeuAspArgLeuAsnThrLeuAlaProLeuProAspGlyPro     128512901295     CTCTCCACGCTGCTCTGGCAGGCGATTGCGGGGGCATGGCCGGCCAGC2175     LeuSerThrLeuLeuTrpGlnAlaIleAlaGlyAlaTrpProAlaSer     130013051310     CGGGAACGCCTTCAGTCCTACGCCCTGAAAGCGGCGCGCGAAGCCGGG2223     ArgGluArgLeuGlnSerTyrAlaLeuLysAlaAlaArgGluAlaGly     131513201325     AACTCGACCAGCTGGACCGATCCGGACCCGGCATTCGAGGAGGCACTT2271     AsnSerThrSerTrpThrAspProAspProAlaPheGluGluAlaLeu     133013351340     TCCGCCGTCGTCGACTCCGCCTTCGACAATCCGGAGGTGCGTGCGGAA2319     SerAlaValValAspSerAlaPheAspAsnProGluValArgAlaGlu     1345135013551360     CTTGAGGCCCTGGTGGGCCTCCTTGCGCCGCACGGTGCGTCCAACTCG2367     LeuGluAlaLeuValGlyLeuLeuAlaProHisGlyAlaSerAsnSer     136513701375     CTCGCGGCAAAGCTTGTCCAGCTGACCATGCCGGGCGTTCCGGACGTG2415     LeuAlaAlaLysLeuValGlnLeuThrMetProGlyValProAspVal     138013851390     TACCAGGGCACCGAGTTCTGGGACAGGTCGCTGACCGATCCGGACAAC2463     TyrGlnGlyThrGluPheTrpAspArgSerLeuThrAspProAspAsn     139514001405     CGGCGCCCCTTCAGCTTCGCCGAACGGATTAGGGCCTTGGACCAGTTG2511     ArgArgProPheSerPheAlaGluArgIleArgAlaLeuAspGlnLeu     141014151420     GACGCCGGCCACCGTCCGGACTCCTTCCAGGACGAGGCGGTCAAGCTG2559     AspAlaGlyHisArgProAspSerPheGlnAspGluAlaValLysLeu     1425143014351440     CTGGTCACCTCGAGGGCGCTGCGGCTGCGGCGGAACCGGCCCGAGCTC2607     LeuValThrSerArgAlaLeuArgLeuArgArgAsnArgProGluLeu     144514501455     TTCACCGGCTACCGCCCCGTGCATGCCAGGGGCCCCGCCGCCGGGCAC2655     PheThrGlyTyrArgProValHisAlaArgGlyProAlaAlaGlyHis     146014651470     CTGGTGGCGTTCGACCGCGGCGCCGGGGGAGTGCTGGCGCTTGCCACC2703     LeuValAlaPheAspArgGlyAlaGlyGlyValLeuAlaLeuAlaThr     147514801485     CGGCTCCCCTACGGGCTGGAACAGTCGGGCGGCTGGCGGGACACCGCC2751     ArgLeuProTyrGlyLeuGluGlnSerGlyGlyTrpArgAspThrAla     149014951500     GTCGAGCTTGAAGCCGCCATGACGGACGAACTGACCGGCTCCACTTTC2799     ValGluLeuGluAlaAlaMetThrAspGluLeuThrGlySerThrPhe     1505151015151520     GGGCCGGGACCGGCGGCGCTGTCAGAAGTCTTCCGGGCCTACCCGGTG2847     GlyProGlyProAlaAlaLeuSerGluValPheArgAlaTyrProVal     152515301535     GCCTTGTTGGTCCCCGCGACAGGAGGCAAGTCATGACGCAGCCCAACGATGCG2900     AlaLeuLeuValProAlaThrGlyGlyLysSer     15401545     GCCAAGCCGGTGCAGGGAGCGGGGCGCTTCGATATC2936     (2) INFORMATION FOR SEQ ID NO:11:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 3073 base pairs     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: cDNA     (ix) FEATURE:     (A) NAME/KEY: CDS     (B) LOCATION: 678..3002     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:     GATCCGGACGGCAACCTCATGTCCCCGGAGGACTGGGACAGCGGCTTCGGCCGTTCGGTG60     GGCATGTTCCTCAACGGCGACGGCATCCAGGGCCACGATGACCGCGGCCGCCGCATCACG120     GACGTGAACTTCCTGCTGTACTTCAACGCCCACGACGGCGACGTCGAGTTCACGCTGCCG180     CCGGACGAATACGCCCCGGCCTGGGACGTCATCATCGACACCGCCGGTGAAGGGGCCGAC240     TCCAAGCCCGCGGACGCCGGAACCATCCTGTCCGTTGCGGCCAAGTCGCTGGTTGTGCTT300     CGCGCCCACAGCGCACCGGAGGAGGAGCCTGACCATTCCGTGGCTGCTTCCCTGGCTGCA360     CTGACGCAGACCGCCACCGCCGAGACGGCGGCGCTCACAGCTCCTGCCGTTCCCGAGCCG420     GCCAAGACGAAGAAGCCGGCCGCTGACCCGGTTGCTGAACCGGCCGACCCGCCGGTTGCT480     GACCCGGCCGACCCGGTTGCTGACCCGGTTGCTGACCCGGCGCCGGAACCGGCTGCGGAG540     CCTGCGAAATCCGCAGCGGAACCTGGTGCGGAGCCTGCGAAGGACCCGGAGGAGCAGCCG600     GCGGAAAAGCCGGCGCGCAAGCCTGCGGCAAAGCGCGGCGGCCACCTGAGGGCGGTCAAG660     CCCGCTGGGGAGGACGCATGAGAACGCCAGTCTCCACGTACAGGCTGCAG710     MetArgThrProValSerThrTyrArgLeuGln     775780     ATCAGGAAGGGATTCACACTCTTCGACGCGGCCAAAACCGTTCCGTAC758     IleArgLysGlyPheThrLeuPheAspAlaAlaLysThrValProTyr     785790795     CTGCACTCGCTCGGCGTCGACTGGGTCTACCTTTCTCCGGTCCTGACT806     LeuHisSerLeuGlyValAspTrpValTyrLeuSerProValLeuThr     800805810815     GCCGAGCAGGGCTCCGACCACGGGTACGACGTCACCGATCCCTCCGCC854     AlaGluGlnGlySerAspHisGlyTyrAspValThrAspProSerAla     820825830     GTCGACCCCGAACGCGGCGGGCCGGAGGGCCTCGCGGCGGTTTCCAAG902     ValAspProGluArgGlyGlyProGluGlyLeuAlaAlaValSerLys     835840845     GCGGCCCGCGCCGCGGGCATGGGCGTGCTGATCGACATCGTGCCCAAC950     AlaAlaArgAlaAlaGlyMetGlyValLeuIleAspIleValProAsn     850855860     CACGTGGGCGTCGCGACGCCGGCGCAGAACCCCTGGTGGTGGTCGCTG998     HisValGlyValAlaThrProAlaGlnAsnProTrpTrpTrpSerLeu     865870875     CTCAAGGAGGGACGCCAGTCCCGTTACGCGGAGGCGTTCGACGTCGAT1046     LeuLysGluGlyArgGlnSerArgTyrAlaGluAlaPheAspValAsp     880885890895     TGGGACCTCGCCGGGGGACGCATCCGGCTGCCGGTGCTCGGCAGCGAC1094     TrpAspLeuAlaGlyGlyArgIleArgLeuProValLeuGlySerAsp     900905910     GATGACCTCGACCAGCTCGAAATCAGGGACGGGGAGCTGCGGTACTAC1142     AspAspLeuAspGlnLeuGluIleArgAspGlyGluLeuArgTyrTyr     915920925     GACCACCGATTCCCGCTCGCCGAGGGAACCTACGCCGAAGGCGACGCC1190     AspHisArgPheProLeuAlaGluGlyThrTyrAlaGluGlyAspAla     930935940     CCGCGGGATGTCCACGCCCGGCAGCACTACGAGCTCATCGGCTGGCGC1238     ProArgAspValHisAlaArgGlnHisTyrGluLeuIleGlyTrpArg     945950955     CGCGCGGACAACGAGCTGAACTACCGCCGCTTTTTCGCGGTGAACACG1286     ArgAlaAspAsnGluLeuAsnTyrArgArgPhePheAlaValAsnThr     960965970975     CTCGCCGGCGTCCGCGTGGAAATCCCCGCCGTCTTCGACGAGGCACAC1334     LeuAlaGlyValArgValGluIleProAlaValPheAspGluAlaHis     980985990     CAGGAGGTGGTGCGCTGGTTCCGCGAGGACCTTGCGGACGGCCTGCGG1382     GlnGluValValArgTrpPheArgGluAspLeuAlaAspGlyLeuArg     99510001005     ATCGACCACCCGGACGGCCTCGCTGACCCCGAGGGGTACCTGAAGCGA1430     IleAspHisProAspGlyLeuAlaAspProGluGlyTyrLeuLysArg     101010151020     CTCCGGGAAGTCACCGGCGGCGCTTACCTGCTGATCGAAAAGATCCTG1478     LeuArgGluValThrGlyGlyAlaTyrLeuLeuIleGluLysIleLeu     102510301035     GAGCCGGGGGAGCAGCTGCCCGCCAGCTTCGAGTGTGAAGGCACCACA1526     GluProGlyGluGlnLeuProAlaSerPheGluCysGluGlyThrThr     1040104510501055     GGCTACGACGCCCTCGCCGACGTCGACCGGGTTCTCGTGGACCCGCGC1574     GlyTyrAspAlaLeuAlaAspValAspArgValLeuValAspProArg     106010651070     GGCCAGGAACCGCTGGACCGGCTTGACGCGTCCCTGCGTGGCGGCGAG1622     GlyGlnGluProLeuAspArgLeuAspAlaSerLeuArgGlyGlyGlu     107510801085     CCCGCCGACTACCAGGACATGATCCGCGGAACCAAGCGCCGGATCACC1670     ProAlaAspTyrGlnAspMetIleArgGlyThrLysArgArgIleThr     109010951100     GACGGTATCCTGCACTCGGAGATCCTGCGGCTGGCCCGGCTGGTTCCG1718     AspGlyIleLeuHisSerGluIleLeuArgLeuAlaArgLeuValPro     110511101115     GGCGACGCCAACGTTTCAATCGACGCCGGAGCCGACGCTCTCGCCGAA1766     GlyAspAlaAsnValSerIleAspAlaGlyAlaAspAlaLeuAlaGlu     1120112511301135     ATCATCGCCGCCTTCCCGGTCTACCGCACCTACCTGCCGGAGGGCGCC1814     IleIleAlaAlaPheProValTyrArgThrTyrLeuProGluGlyAla     114011451150     GAGGTCCTGAAGGAGGCGTGCGAGCTTGCCGCGCGTAGGCGGCCGGAA1862     GluValLeuLysGluAlaCysGluLeuAlaAlaArgArgArgProGlu     115511601165     CTCGACCAGGCCATCCAGGCTCTGCAGCCGCTGCTGCTGGACACGGAC1910     LeuAspGlnAlaIleGlnAlaLeuGlnProLeuLeuLeuAspThrAsp     117011751180     CTCGAGCTTGCCCGGCGCTTCCAGCAGACCTCGGGCATGGTCATGGCC1958     LeuGluLeuAlaArgArgPheGlnGlnThrSerGlyMetValMetAla     118511901195     AAGGGCGTGGAGGACACCGCGTTCTTCCGCTACAACCGCCTGGGCACC2006     LysGlyValGluAspThrAlaPhePheArgTyrAsnArgLeuGlyThr     1200120512101215     CTCACGGAAGTGGGCGCCGACCCCACCGAGTTCGCCGTGGAGCCGGAC2054     LeuThrGluValGlyAlaAspProThrGluPheAlaValGluProAsp     122012251230     GAGTTCCACGCCCGGCTGGCACGCCGGCAGGCCGAGCTTCCGCTGTCC2102     GluPheHisAlaArgLeuAlaArgArgGlnAlaGluLeuProLeuSer     123512401245     ATGACGACGCTGAGCACGCACGACACCAAGCGCAGCGAGGACACCCGA2150     MetThrThrLeuSerThrHisAspThrLysArgSerGluAspThrArg     125012551260     GCAAGGATTTCGGTCATTTCCGAGGTTGCGGGTGACTGGGAAAAGGCC2198     AlaArgIleSerValIleSerGluValAlaGlyAspTrpGluLysAla     126512701275     TTGAACCGGCTGCGCGACCTGGCCCCGCTGCCGGACGGCCCGCTGTCC2246     LeuAsnArgLeuArgAspLeuAlaProLeuProAspGlyProLeuSer     1280128512901295     GCGCTGCTCTGGCAGGCCATTGCCGGCGCCTGGCCCGCCAGCCGGGAA2294     AlaLeuLeuTrpGlnAlaIleAlaGlyAlaTrpProAlaSerArgGlu     130013051310     CGCCTGCAGTACTACGCGCTGAAGGCCGCGCGTGAAGCGGGGAACTCG2342     ArgLeuGlnTyrTyrAlaLeuLysAlaAlaArgGluAlaGlyAsnSer     131513201325     ACCAACTGGACCGATCCGGCCCCCGCGTTCGAGGAGAAGCTGAAGGCC2390     ThrAsnTrpThrAspProAlaProAlaPheGluGluLysLeuLysAla     133013351340     GCGGTCGACGCCGTGTTCGACAATCCCGCCGTGCAGGCCGAGGTGGAA2438     AlaValAspAlaValPheAspAsnProAlaValGlnAlaGluValGlu     134513501355     GCCCTCGTCGAGCTCCTGGAGCCGTACGGAGCTTCGAACTCCCTCGCC2486     AlaLeuValGluLeuLeuGluProTyrGlyAlaSerAsnSerLeuAla     1360136513701375     GCCAAGCTCGTGCAGCTGACCATGCCCGGCGTCCCGGACGTCTACCAG2534     AlaLysLeuValGlnLeuThrMetProGlyValProAspValTyrGln     138013851390     GGCACGGAGTTCTGGGACCGGTCGCTGACGGACCCGGACAACCGGCGG2582     GlyThrGluPheTrpAspArgSerLeuThrAspProAspAsnArgArg     139514001405     CCGTTCAGCTTCGACGACCGCCGCGCCGCGCTGGAGCAGCTGGATGCC2630     ProPheSerPheAspAspArgArgAlaAlaLeuGluGlnLeuAspAla     141014151420     GGCGACCTTCCCGCGTCATTTACCGATGAGCGGACGAAGCTGCTAGTG2678     GlyAspLeuProAlaSerPheThrAspGluArgThrLysLeuLeuVal     142514301435     ACGTCGCGCGCGCTGCGGCTGCGCCGGGACCGTCCGGAGCTGTTCACG2726     ThrSerArgAlaLeuArgLeuArgArgAspArgProGluLeuPheThr     1440144514501455     GGGTACCGGCCGGTCCTGGCCAGCGGGCCCGCCGCCGGGCACCTGCTC2774     GlyTyrArgProValLeuAlaSerGlyProAlaAlaGlyHisLeuLeu     146014651470     GCGTTCGACCGCGGCACCGCGGCGGCGCCGGGTGCATTGACCCTCGCC2822     AlaPheAspArgGlyThrAlaAlaAlaProGlyAlaLeuThrLeuAla     147514801485     ACGCGGCTTCCCTACGGGCTGGAACAGTCGGGTGGATGGCGGGACACC2870     ThrArgLeuProTyrGlyLeuGluGlnSerGlyGlyTrpArgAspThr     149014951500     GCCGTCGAACTTAACACCGCCATGAAAGACGAACTGACCGGTGCCGGC2918     AlaValGluLeuAsnThrAlaMetLysAspGluLeuThrGlyAlaGly     150515101515     TTCGGACCGGGGGCAGTGAAGATCGCCGACATCTTCCGGTCGTTCCCC2966     PheGlyProGlyAlaValLysIleAlaAspIlePheArgSerPhePro     1520152515301535     GTTGCGCTGCTGGTGCCGCAGACAGGAGGAGAGTCATGACGCACAC3012     ValAlaLeuLeuValProGlnThrGlyGlyGluSer     15401545     CTACCCGCGGGAAGCCGCGAAACCCGTCCTGGGCCCCGCACGCTACGACGTCTGGGCGCC3072     C3073     (2) INFORMATION FOR SEQ ID NO:12:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 20 amino acids     (B) TYPE: amino acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: peptide     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:     MetArgThrProAlaSerThrTyrArgLeuGlnIleArgArgGlyPhe     151015     ThrLeuPheAsp     20     (2) INFORMATION FOR SEQ ID NO:13:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 20 amino acids     (B) TYPE: amino acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: peptide     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:     MetArgThrProValSerThrTyrArgLeuGlnIleArgLysGlyPhe     151015     ThrLeuPheAsp     20     (2) INFORMATION FOR SEQ ID NO:14:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 21 amino acids     (B) TYPE: amino acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: peptide     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:     ArgSerGluAspThrArgAlaArgIleSerValIleAlaGluValAla     151015     ProGluTrpGluLys     20     (2) INFORMATION FOR SEQ ID NO:15:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 21 amino acids     (B) TYPE: amino acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: peptide     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:     LeuValGlnLeuThrMetProGlyValProAspValTyrGlnGlyThr     151015     GluPheTrpAspArg     20     (2) INFORMATION FOR SEQ ID NO:16:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 20 amino acids     (B) TYPE: amino acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: peptide     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:     LeuValGlnLeuThrMetProGlyValProAspValTyrGlnGlyThr     151015     GluPheTrpAsp     20     (2) INFORMATION FOR SEQ ID NO:17:     (i) SEQUENCE CHARACTERISTICS:     (A) LENGTH: 20 amino acids     (B) TYPE: amino acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear     (ii) MOLECULE TYPE: peptide     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:     GluGlyArgGlnSerArgTyrAlaGluAlaPheAspValAspTrpAsp     151015     LeuAlaGlyGly     20     __________________________________________________________________________ 

We claim:
 1. An isolated enzyme having an activity which forms a non-reducing saccharide having a trehalose structure as an end unit from a reducing amylaceous saccharide having a degree of glucose polymerization of 3 or higher, wherein said isolated enzyme is a variant of an enzyme having the sequence of SEQ ID NO:2 or SEQ ID NO:4 not derived from a microorganism selected from the group consisting of Brevibacteriuum, Flavobacterium, Micrococcus, Curtobacterium, Mycobacterium and Terrabacter, said variant having more than one amino acid residue in SEQ ID NO:2 or SEQ ID NO:4 replaced with different amino acids and having substantially the same activity as the enzyme of SEQ ID NO:2 or SEQ ID NO:4.
 2. An isolated enzyme having an activity which forms a non-reducing saccharide having a trehalose structure as an end unit from a reducing amylaceous saccharide having a degree of glucose polymerization of 3 or higher, wherein said isolated enzyme is a variant of an enzyme having the sequence of SEQ ID NO:2 or SEQ ID NO:4 not derived from a microorganism selected from the group consisting of Brevibacterium, Flavobacterium, Micrococcus, Curtobacterium, Mycobacterium and Terrabacter, said variant having more than one amino acid residue deleted from or added to the N-terminus of SEQ ID NO:2 or SEQ ID NO:4 and having substantially the same activity as the enzyme of SEQ ID NO:2 or SEQ ID NO:4. 